Home Alzheimer's Genes AD risk factors Bipolar Genes BP risk factors Autism risk factors.Schizophrenia Genes SZ Risk factors Anorexia genes and risk factors .Chronic Fatigue Risk Factors. Multiple sclerosis risk factors . Parkinson's disease genes and risk factors Cystic Fibrosis Herpes simplex database Jobs in genetics and bioinformatics Pathogens Pathways Useful links Videos . Subscribe to Site Updates by Email  Subscribe in a reader . .........................................................

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

These maps, etched out by numerous Bipolar disorder susceptibility gene candidates are generated by Kegg pathways from the Kanehisa laboratories with thanks and are subject to their copyright conditions: Genes are enhanced by Click on "show all objects" for genes within figures

Pathway Search Result

hsa04080 Neuroactive ligand-receptor interaction - Homo sapiens (human) (42)



hsa:624 BDKRB2, B2R, BK-2, BK2, BKR2, BRB2, DKFZp686O088; bradykinin receptor B2; K03916 bradykinin receptor B2
hsa:1129 CHRM2, FLJ43243, HM2, MGC120006, MGC120007; cholinergic receptor, muscarinic 2; K04130 muscarinic acetylcholine receptor M2
hsa:8973 CHRNA6, CHNRA6; cholinergic receptor, nicotinic, alpha 6; K04808 nicotinic acetylcholine receptor alpha-6
hsa:1139 CHRNA7, CHRNA7-2, NACHRA7; cholinergic receptor, nicotinic, alpha 7; K04809 nicotinic acetylcholine receptor alpha-7
hsa:1142 CHRNB3; cholinergic receptor, nicotinic, beta 3; K04814 nicotinic acetylcholine receptor beta-3
hsa:1812 DRD1, DADR, DRD1A; dopamine receptor D1; K04144 dopamine receptor D1
hsa:1813 DRD2, D2DR, D2R; dopamine receptor D2; K04145 dopamine receptor D2
hsa:1814 DRD3, D3DR, ETM1, FET1, MGC149204, MGC149205; dopamine receptor D3; K04146 dopamine receptor D3
hsa:9568 GABBR2, FLJ36928, GABABR2, GPR51, GPRC3B, HG20, HRIHFB2099; gamma-aminobutyric acid (GABA) B receptor, 2; K04616 gamma-aminobutyric acid (GABA) B receptor 2
hsa:2554 GABRA1, ECA4, EJM, EJM5; gamma-aminobutyric acid (GABA) A receptor, alpha 1; K05175 gamma-aminobutyric acid (GABA) A receptor alpha-1
hsa:2557 GABRA4; gamma-aminobutyric acid (GABA) A receptor, alpha 4; K05178 gamma-aminobutyric acid (GABA) A receptor alpha-4
hsa:2558 GABRA5, MGC138184; gamma-aminobutyric acid (GABA) A receptor, alpha 5; K05179 gamma-aminobutyric acid (GABA) A receptor alpha-5
hsa:2560 GABRB1; gamma-aminobutyric acid (GABA) A receptor, beta 1; K05181 gamma-aminobutyric acid (GABA) A receptor beta-1
hsa:2561 GABRB2, MGC119386, MGC119388, MGC119389; gamma-aminobutyric acid (GABA) A receptor, beta 2; K05182 gamma-aminobutyric acid (GABA) A receptor beta-2
hsa:2562 GABRB3, ECA5, MGC9051; gamma-aminobutyric acid (GABA) A receptor, beta 3; K05183 gamma-aminobutyric acid (GABA) A receptor beta-3
hsa:2569 GABRR1, MGC163216; gamma-aminobutyric acid (GABA) receptor, rho 1; K05190 gamma-aminobutyric acid (GABA) receptor rho-1
hsa:9248 GPR50, H9, MGC125342, Mel1c; G protein-coupled receptor 50; K04287 G protein-coupled receptor 50
hsa:2890 GRIA1, GLUH1, GLUR1, GLURA, GluA1, HBGR1, MGC133252; glutamate receptor, ionotropic, AMPA 1; K05197 glutamate receptor, ionotropic, AMPA 1
hsa:2894 GRID1, KIAA1220; glutamate receptor, ionotropic, delta 1; K05206 glutamate receptor, ionotropic, delta 1
hsa:2900 GRIK4, EAA1, GRIK, KA1; glutamate receptor, ionotropic, kainate 4; K05204 glutamate receptor, ionotropic, kainate 4
hsa:2901 GRIK5, EAA2, GRIK2, KA2; glutamate receptor, ionotropic, kainate 5; K05205 glutamate receptor, ionotropic, kainate 5
hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1
hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:2904 GRIN2B, MGC142178, MGC142180, NMDAR2B, NR2B, hNR3; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; K05210 glutamate receptor, ionotropic, N-methyl-D-aspartate 2B
hsa:2911 GRM1, GPRC1A, GRM1A, MGLUR1, MGLUR1A, mGlu1; glutamate receptor, metabotropic 1; K04604 metabotropic glutamate receptor 1/5
hsa:2913 GRM3, GLUR3, GPRC1C, MGLUR3, mGlu3; glutamate receptor, metabotropic 3; K04605 metabotropic glutamate receptor 2/3
hsa:2914 GRM4, GPRC1D, MGC177594, MGLUR4, mGlu4; glutamate receptor, metabotropic 4; K04607 metabotropic glutamate receptor 4
hsa:2917 GRM7, FLJ40498, GLUR7, GPRC1G, MGLU7, MGLUR7; glutamate receptor, metabotropic 7; K04608 metabotropic glutamate receptor 6/7/8
hsa:3356 HTR2A, 5-HT2A, HTR2; 5-hydroxytryptamine (serotonin) receptor 2A; K04157 5-hydroxytryptamine receptor 2
hsa:3358 HTR2C, 5-HT2C, 5-HTR2C, HTR1C; 5-hydroxytryptamine (serotonin) receptor 2C; K04157 5-hydroxytryptamine receptor 2
hsa:3360 HTR4, 5-HT4, 5-HT4R; 5-hydroxytryptamine (serotonin) receptor 4; K04160 5-hydroxytryptamine receptor 4
hsa:3361 HTR5A, 5-HT5A, MGC138226; 5-hydroxytryptamine (serotonin) receptor 5A; K04161 5-hydroxytryptamine receptor 5
hsa:3362 HTR6, 5-HT6, 5-HT6R; 5-hydroxytryptamine (serotonin) receptor 6; K04162 5-hydroxytryptamine receptor 6
hsa:4161 MC5R, MC2; melanocortin 5 receptor; K04203 melanocortin 5 receptor
hsa:2847 MCHR1, GPR24, MCH1R, MGC32129, SLC1; melanin-concentrating hormone receptor 1; K04320 melanin-concentrating hormone receptor 1
hsa:84539 MCHR2, GPR145, GPRv17, MCH-2R, MCH-R2, MCH2, MCH2R, MCHR-2, SLT; melanin-concentrating hormone receptor 2; K05054 melanin-concentrating hormone receptor 2
hsa:2908 NR3C1, GCCR, GCR, GR, GRL; nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor); K05771 glucocorticoid receptor
hsa:5027 P2RX7, MGC20089, P2X7; purinergic receptor P2X, ligand-gated ion channel, 7; K05220 purinergic receptor P2X, ligand-gated ion channel 7
hsa:6755 SSTR5, SS-5-R; somatostatin receptor 5; K04221 somatostatin receptor 5
hsa:319100 TAAR6, RP11-295F4.3, TA4, TAR4, TAR6, TRAR4; trace amine associated receptor 6; K05051 trace amine associated receptor
hsa:6869 TACR1, NK1R, NKIR, SPR, TAC1R; tachykinin receptor 1; K04222 tachykinin receptor 1
hsa:7068 THRB, ERBA-BETA, ERBA2, GRTH, MGC126109, MGC126110, NR1A2, PRTH, THR1, THRB1, THRB2; thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian); K08362 thyroid hormone receptor beta

hsa01100 Metabolic pathways - Homo sapiens (human) (41)

hsa:217 ALDH2, ALDH-E2, ALDHI, ALDM, MGC1806; aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3); K00128 aldehyde dehydrogenase (NAD+) [EC:1.2.1.3]
hsa:79796 ALG9, CDG1L, DIBD1, DKFZp586M2420, FLJ21845, LOH11CR1J; asparagine-linked glycosylation 9, alpha-1,2-mannosyltransferase homolog (S. cerevisiae); K03846 alpha-1,2-mannosyltransferase [EC:2.4.1.-]
hsa:239 ALOX12, 12-LOX, 12S-LOX, LOG12; arachidonate 12-lipoxygenase (EC:1.13.11.31); K00458 arachidonate 12-lipoxygenase [EC:1.13.11.31]
hsa:9114 ATP6V0D1, ATP6D, ATP6DV, FLJ43534, P39, VATX, VMA6, VPATPD; ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 (EC:3.6.3.14); K02146 V-type H+-transporting ATPase subunit AC39 [EC:3.6.3.14]
hsa:10317 B3GALT5, B3GalT-V, B3GalTx, B3T5, GLCT5, beta3Gal-T5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5; K03877 beta-1,3-galactosyltransferase 5 [EC:2.4.1.-]
hsa:1312 COMT; catechol-O-methyltransferase (EC:2.1.1.6); K00545 catechol O-methyltransferase [EC:2.1.1.6]
hsa:1610 DAO, DAAO, DAMOX, MGC35381, OXDA; D-amino-acid oxidase (EC:1.4.3.3); K00273 D-amino-acid oxidase [EC:1.4.3.3]
hsa:1644 DDC, AADC; dopa decarboxylase (aromatic L-amino acid decarboxylase) (EC:4.1.1.28); K01593 aromatic-L-amino-acid decarboxylase [EC:4.1.1.28]
hsa:160851 DGKH, DGKeta, DKFZp761I1510; diacylglycerol kinase, eta (EC:2.7.1.107); K00901 diacylglycerol kinase [EC:2.7.1.107]
hsa:2134 EXTL1, EXTL, MGC70794; exostoses (multiple)-like 1 (EC:2.4.1.224); K02368 alpha-1,4-N-acetylglucosaminyltransferase EXTL1 [EC:2.4.1.224]
hsa:2539 G6PD, G6PD1; glucose-6-phosphate dehydrogenase (EC:1.1.1.49); K00036 glucose-6-phosphate 1-dehydrogenase [EC:1.1.1.49]
hsa:2571 GAD1, FLJ45882, GAD, SCP; glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15); K01580 glutamate decarboxylase [EC:4.1.1.15]
hsa:374378 GALNTL4, GALNT15, GALNT18, GalNAc-T15, MGC71806; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 4 (EC:2.4.1.41); K00710 polypeptide N-acetylgalactosaminyltransferase [EC:2.4.1.41]
hsa:2643 GCH1, DYT14, DYT5, DYT5a, GCH, GTP-CH-1, GTPCH1, HPABH4B; GTP cyclohydrolase 1 (EC:3.5.4.16); K01495 GTP cyclohydrolase I [EC:3.5.4.16]
hsa:3099 HK2, DKFZp686M1669, HKII, HXK2; hexokinase 2 (EC:2.7.1.1); K00844 hexokinase [EC:2.7.1.1]
hsa:3613 IMPA2; inositol(myo)-1(or 4)-monophosphatase 2 (EC:3.1.3.25); K01092 myo-inositol-1(or 4)-monophosphatase [EC:3.1.3.25]
hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]
hsa:4522 MTHFD1, MTHFC, MTHFD; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase (EC:1.5.1.5 6.3.4.3 3.5.4.9); K00288 methylenetetrahydrofolate dehydrogenase (NADP+) / methenyltetrahydrofolate cyclohydrolase / formyltetrahydrofolate synthetase [EC:1.5.1.5 3.5.4.9 6.3.4.3]
hsa:4524 MTHFR; methylenetetrahydrofolate reductase (NAD(P)H) (EC:1.5.1.20); K00297 methylenetetrahydrofolate reductase (NADPH) [EC:1.5.1.20]
hsa:4548 MTR, FLJ33168, FLJ43216, FLJ45386, MS, cblG; 5-methyltetrahydrofolate-homocysteine methyltransferase (EC:2.1.1.13); K00548 5-methyltetrahydrofolate--homocysteine methyltransferase [EC:2.1.1.13]
hsa:4535 ND1, MTND1; NADH dehydrogenase, subunit 1 (complex I); K03878 NADH dehydrogenase I subunit 1 [EC:1.6.5.3]
hsa:4538 ND4, MTND4; NADH dehydrogenase, subunit 4 (complex I); K03881 NADH dehydrogenase I subunit 4 [EC:1.6.5.3]
hsa:4539 ND4L, MTND4L; NADH dehydrogenase, subunit 4L (complex I); K03882 NADH dehydrogenase I subunit 4L [EC:1.6.5.3]
hsa:4706 NDUFAB1, ACP, FASN2A, MGC65095, SDAP; NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa; K03955 NADH dehydrogenase (ubiquinone) 1 alpha/beta subcomplex 1 [EC:1.6.5.3 1.6.99.3]
hsa:4729 NDUFV2, CI-24k; NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa (EC:1.6.5.3 1.6.99.3); K03943 NADH dehydrogenase (ubiquinone) flavoprotein 2 [EC:1.6.5.3 1.6.99.3]
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:4846 NOS3, ECNOS, eNOS; nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39); K13242 nitric-oxide synthase, endothelial [EC:1.14.13.39]
hsa:5289 PIK3C3, MGC61518, VPS34, hVps34; phosphoinositide-3-kinase, class 3 (EC:2.7.1.137); K00914 phosphatidylinositol 3-kinase [EC:2.7.1.137]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:51196 PLCE1, FLJ23659, KIAA1516, MGC167842, NPHS3, PLCE, PPLC; phospholipase C, epsilon 1 (EC:3.1.4.11); K05860 phospholipase C, epsilon
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5427 POLE2, DPE2; polymerase (DNA directed), epsilon 2 (p59 subunit) (EC:2.7.7.7); K02325 DNA polymerase epsilon subunit 2 [EC:2.7.7.7]
hsa:5740 PTGIS, CYP8, CYP8A1, MGC126858, MGC126860, PGIS, PTGI; prostaglandin I2 (prostacyclin) synthase (EC:5.3.99.4); K01831 cytochrome P450, family 8, subfamily A (Prostacyclin synthase) [EC:5.3.99.4]
hsa:6697 SPR, SDR38C1; sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase) (EC:1.1.1.153); K00072 sepiapterin reductase [EC:1.1.1.153]
hsa:55304 SPTLC3, C20orf38, FLJ11112, FLJ90790, LCB2B, LCB3, SPT3, SPTLC2L, dJ718P11, dJ718P11.1; serine palmitoyltransferase, long chain base subunit 3 (EC:2.3.1.50); K00654 serine palmitoyltransferase [EC:2.3.1.50]
hsa:6482 ST3GAL1, DKFZp666E036, DKFZp779K2051, FLJ36548, Gal-NAc6S, MGC9183, SIAT4A, SIATFL, ST3GalA, ST3GalA.1, ST3GalIA, ST3GalIA,1, ST3O; ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (EC:2.4.99.4); K00780 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4A) [EC:2.4.99.4]
hsa:8867 SYNJ1, INPP5G; synaptojanin 1 (EC:3.1.3.36); K01099 phosphatidylinositol-bisphosphatase [EC:3.1.3.36]
hsa:6999 TDO2, TDO, TPH2, TRPO; tryptophan 2,3-dioxygenase (EC:1.13.11.11); K00453 tryptophan 2,3-dioxygenase [EC:1.13.11.11]
hsa:7054 TH, DYT14, DYT5b, TYH; tyrosine hydroxylase (EC:1.14.16.2); K00501 tyrosine 3-monooxygenase [EC:1.14.16.2]
hsa:121278 TPH2, ADHD7, FLJ37295, MGC138871, MGC138872, NTPH; tryptophan hydroxylase 2 (EC:1.14.16.4); K00502 tryptophan 5-monooxygenase [EC:1.14.16.4]

hsa04020 Calcium signaling pathway - Homo sapiens (human) (29)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:624 BDKRB2, B2R, BK-2, BK2, BKR2, BRB2, DKFZp686O088; bradykinin receptor B2; K03916 bradykinin receptor B2
hsa:774 CACNA1B, BIII, CACNL1A5, CACNN, Cav2.2; calcium channel, voltage-dependent, N type, alpha 1B subunit; K04849 voltage-dependent calcium channel N type alpha-1B
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:817 CAMK2D, CAMKD, DKFZp686G23119, DKFZp686I2288, MGC44911; calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:1129 CHRM2, FLJ43243, HM2, MGC120006, MGC120007; cholinergic receptor, muscarinic 2; K04130 muscarinic acetylcholine receptor M2
hsa:1139 CHRNA7, CHRNA7-2, NACHRA7; cholinergic receptor, nicotinic, alpha 7; K04809 nicotinic acetylcholine receptor alpha-7
hsa:1812 DRD1, DADR, DRD1A; dopamine receptor D1; K04144 dopamine receptor D1
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2066 ERBB4, HER4, MGC138404, p180erbB4; v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) (EC:2.7.10.1); K05085 receptor tyrosine-protein kinase erbB-4 [EC:2.7.10.1]
hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1
hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:2911 GRM1, GPRC1A, GRM1A, MGLUR1, MGLUR1A, mGlu1; glutamate receptor, metabotropic 1; K04604 metabotropic glutamate receptor 1/5
hsa:3356 HTR2A, 5-HT2A, HTR2; 5-hydroxytryptamine (serotonin) receptor 2A; K04157 5-hydroxytryptamine receptor 2
hsa:3358 HTR2C, 5-HT2C, 5-HTR2C, HTR1C; 5-hydroxytryptamine (serotonin) receptor 2C; K04157 5-hydroxytryptamine receptor 2
hsa:3360 HTR4, 5-HT4, 5-HT4R; 5-hydroxytryptamine (serotonin) receptor 4; K04160 5-hydroxytryptamine receptor 4
hsa:3361 HTR5A, 5-HT5A, MGC138226; 5-hydroxytryptamine (serotonin) receptor 5A; K04161 5-hydroxytryptamine receptor 5
hsa:3362 HTR6, 5-HT6, 5-HT6R; 5-hydroxytryptamine (serotonin) receptor 6; K04162 5-hydroxytryptamine receptor 6
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:4846 NOS3, ECNOS, eNOS; nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39); K13242 nitric-oxide synthase, endothelial [EC:1.14.13.39]
hsa:5027 P2RX7, MGC20089, P2X7; purinergic receptor P2X, ligand-gated ion channel, 7; K05220 purinergic receptor P2X, ligand-gated ion channel 7
hsa:51196 PLCE1, FLJ23659, KIAA1516, MGC167842, NPHS3, PLCE, PPLC; phospholipase C, epsilon 1 (EC:3.1.4.11); K05860 phospholipase C, epsilon
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:6262 RYR2, ARVC2, ARVD2, VTSIP; ryanodine receptor 2 (cardiac); K04962 ryanodine receptor 2
hsa:291 SLC25A4, AAC1, ANT, ANT1, PEO2, PEO3, T1; solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4; K05863 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator)
hsa:6869 TACR1, NK1R, NKIR, SPR, TAC1R; tachykinin receptor 1; K04222 tachykinin receptor 1

hsa05200 Pathways in cancer - Homo sapiens (human) (22)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:613 BCR, ALL, BCR1, CML, D22S11, D22S662, FLJ16453, PHL; breakpoint cluster region (EC:2.7.11.1); K08878 breakpoint cluster region protein [EC:2.7.11.1]
hsa:675 BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCB, FANCD, FANCD1, GLM3, PNCA2; breast cancer 2, early onset; K08775 breast cancer 2 susceptibility protein
hsa:1029 CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); K06621 cyclin-dependent kinase inhibitor 2A
hsa:1496 CTNNA2, CAP-R, CAPR, CT114, CTNR, DKFZp686H02198; catenin (cadherin-associated protein), alpha 2; K05691 catenin (cadherin-associated protein), alpha
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2535 FZD2, Fz2, fz-2, fzE2, hFz2; frizzled homolog 2 (Drosophila); K02235 frizzled 2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:7184 HSP90B1, ECGP, GP96, GRP94, TRA1; heat shock protein 90kDa beta (Grp94), member 1; K09487 heat shock protein 90kDa beta
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3815 KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
hsa:3909 LAMA3, BM600, E170, LAMNA, LOCS, lama3a; laminin, alpha 3; K06240 laminin, alpha 3/5
hsa:4318 MMP9, CLG4B, GELB, MANDP2, MMP-9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35); K01403 matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5467 PPARD, FAAR, MGC3931, NR1C2, NUC1, NUCI, NUCII, PPARB; peroxisome proliferator-activated receptor delta; K04504 peroxisome proliferator-activated receptor delta
hsa:6258 RXRG, NR2B3, RXRC; retinoid X receptor, gamma; K08526 retinoid X receptor gamma
hsa:83439 TCF7L1, TCF-3, TCF3; transcription factor 7-like 1 (T-cell specific, HMG-box); K04490 transcription factor 7-like 1
hsa:7482 WNT2B, WNT13, XWNT2; wingless-type MMTV integration site family, member 2B; K00182 wingless-type MMTV integration site family, member 2
hsa:7476 WNT7A; wingless-type MMTV integration site family, member 7A; K00572 wingless-type MMTV integration site family, member 7

hsa04010 MAPK signaling pathway - Homo sapiens (human) (16)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:627 BDNF, MGC34632; brain-derived neurotrophic factor; K04355 brain-derived neurotrophic factor
hsa:774 CACNA1B, BIII, CACNL1A5, CACNN, Cav2.2; calcium channel, voltage-dependent, N type, alpha 1B subunit; K04849 voltage-dependent calcium channel N type alpha-1B
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:783 CACNB2, CACNLB2, CAVB2, FLJ23743, MYSB; calcium channel, voltage-dependent, beta 2 subunit; K04863 voltage-dependent calcium channel beta-2
hsa:27091 CACNG5, MGC126656, MGC126682; calcium channel, voltage-dependent, gamma subunit 5; K04870 voltage-dependent calcium channel gamma-5
hsa:994 CDC25B; cell division cycle 25 homolog B (S. pombe) (EC:3.1.3.48); K05866 cell division cycle 25B [EC:3.1.3.48]
hsa:1844 DUSP2, PAC-1, PAC1; dual specificity phosphatase 2 (EC:3.1.3.16 3.1.3.48); K04459 dual specificity phosphatase [EC:3.1.3.16 3.1.3.48]
hsa:1848 DUSP6, MKP3, PYST1; dual specificity phosphatase 6 (EC:3.1.3.16 3.1.3.48); K04459 dual specificity phosphatase [EC:3.1.3.16 3.1.3.48]
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:4915 NTRK2, GP145-TrkB, TRKB; neurotrophic tyrosine kinase, receptor, type 2 (EC:2.7.10.1); K04360 neurotrophic tyrosine kinase receptor type 2 [EC:2.7.10.1]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:10125 RASGRP1, CALDAG-GEFI, CALDAG-GEFII, MGC129998, MGC129999, RASGRP, V, hRasGRP1; RAS guanyl releasing protein 1 (calcium and DAG-regulated); K04350 RAS guanyl-releasing protein 1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04660 T cell receptor signaling pathway - Homo sapiens (human) (13)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1493 CTLA4, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, ICOS, IDDM12; cytotoxic T-lymphocyte-associated protein 4; K06538 cytotoxic T-lymphocyte-associated protein 4
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3702 ITK, EMT, LYK, MGC126257, MGC126258, PSCTK2; IL2-inducible T-cell kinase (EC:2.7.10.2); K07363 IL2-inducible T-cell kinase [EC:2.7.10.2]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:10125 RASGRP1, CALDAG-GEFI, CALDAG-GEFII, MGC129998, MGC129999, RASGRP, V, hRasGRP1; RAS guanyl releasing protein 1 (calcium and DAG-regulated); K04350 RAS guanyl-releasing protein 1
hsa:7006 TEC, MGC126760, MGC126762, PSCTK4; tec protein tyrosine kinase (EC:2.7.10.2); K07364 tec protein tyrosine kinase [EC:2.7.10.2]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene

hsa05010 Alzheimer's disease - Homo sapiens (human) (12)



hsa:348 APOE, AD2, LDLCQ5, LPG, MGC1571; apolipoprotein E; K04524 apolipoprotein E
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1
hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:2904 GRIN2B, MGC142178, MGC142180, NMDAR2B, NR2B, hNR3; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; K05210 glutamate receptor, ionotropic, N-methyl-D-aspartate 2B
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:4706 NDUFAB1, ACP, FASN2A, MGC65095, SDAP; NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa; K03955 NADH dehydrogenase (ubiquinone) 1 alpha/beta subcomplex 1 [EC:1.6.5.3 1.6.99.3]
hsa:4729 NDUFV2, CI-24k; NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa (EC:1.6.5.3 1.6.99.3); K03943 NADH dehydrogenase (ubiquinone) flavoprotein 2 [EC:1.6.5.3 1.6.99.3]
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04380 Osteoclast differentiation - Homo sapiens (human) (11)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1385 CREB1, CREB, MGC9284; cAMP responsive element binding protein 1; K05870 cAMP response element-binding protein 1
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:9846 GAB2, KIAA0571; GRB2-associated binding protein 2; K08091 growth factor receptor bound protein 2-associated protein 2
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:6850 SYK, DKFZp313N1010, FLJ25043, FLJ37489; spleen tyrosine kinase (EC:2.7.10.2); K05855 spleen tyrosine kinase [EC:2.7.10.2]
hsa:7006 TEC, MGC126760, MGC126762, PSCTK4; tec protein tyrosine kinase (EC:2.7.10.2); K07364 tec protein tyrosine kinase [EC:2.7.10.2]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04060 Cytokine-cytokine receptor interaction - Homo sapiens (human) (11)



hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:1439 CSF2RB, CD131, CDw131, IL3RB, IL5RB; colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); K04738 cytokine receptor common subunit beta
hsa:1896 EDA, ED1, ED1-A1, ED1-A2, EDA1, EDA2, HED, STHAGX1, XHED, XLHED; ectodysplasin A; K05480 ectodysplasin-A
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3560 IL2RB, CD122, P70-75; interleukin 2 receptor, beta; K05069 interleukin 2 receptor beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3815 KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04510 Focal adhesion - Homo sapiens (human) (11)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3909 LAMA3, BM600, E170, LAMNA, LOCS, lama3a; laminin, alpha 3; K06240 laminin, alpha 3/5
hsa:10627 MYL12A, MLCB, MRCL3, MRLC3, MYL2B; myosin, light chain 12A, regulatory, non-sarcomeric; K12757 myosin regulatory light chain 12
hsa:103910 MYL12B, MLC-B, MRLC2; myosin, light chain 12B, regulatory; K12757 myosin regulatory light chain 12
hsa:5649 RELN, PRO1598, RL; reelin; K06249 reelin [EC:3.4.21.-]
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene

hsa04722 Neurotrophin signaling pathway - Homo sapiens (human) (11)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:627 BDNF, MGC34632; brain-derived neurotrophic factor; K04355 brain-derived neurotrophic factor
hsa:817 CAMK2D, CAMKD, DKFZp686G23119, DKFZp686I2288, MGC44911; calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:4915 NTRK2, GP145-TrkB, TRKB; neurotrophic tyrosine kinase, receptor, type 2 (EC:2.7.10.1); K04360 neurotrophic tyrosine kinase receptor type 2 [EC:2.7.10.1]
hsa:4916 NTRK3, TRKC, gp145(trkC); neurotrophic tyrosine kinase, receptor, type 3 (EC:2.7.10.1); K05101 neurotrophic tyrosine kinase, receptor type 3 [EC:2.7.10.1]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:7533 YWHAH, YWHA1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:10782 ZNF274, DKFZp686K08243, FLJ37843, HFB101, ZF2, ZKSCAN19; zinc finger protein 274; K12458 zinc finger protein 274

hsa05142 Chagas disease (American trypanosomiasis) - Homo sapiens (human) (10)



hsa:1636 ACE, ACE1, CD143, DCP, DCP1, MGC26566, MVCD3; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1); K01283 peptidyl-dipeptidase A [EC:3.4.15.1]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:624 BDKRB2, B2R, BK-2, BK2, BKR2, BRB2, DKFZp686O088; bradykinin receptor B2; K03916 bradykinin receptor B2
hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:5522 PPP2R2C, B55-GAMMA, IMYPNO, IMYPNO1, MGC33570, PR52, PR55G; protein phosphatase 2, regulatory subunit B, gamma (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04916 Melanogenesis - Homo sapiens (human) (10)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:817 CAMK2D, CAMKD, DKFZp686G23119, DKFZp686I2288, MGC44911; calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:1385 CREB1, CREB, MGC9284; cAMP responsive element binding protein 1; K05870 cAMP response element-binding protein 1
hsa:2535 FZD2, Fz2, fz-2, fzE2, hFz2; frizzled homolog 2 (Drosophila); K02235 frizzled 2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3815 KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
hsa:83439 TCF7L1, TCF-3, TCF3; transcription factor 7-like 1 (T-cell specific, HMG-box); K04490 transcription factor 7-like 1
hsa:7482 WNT2B, WNT13, XWNT2; wingless-type MMTV integration site family, member 2B; K00182 wingless-type MMTV integration site family, member 2
hsa:7476 WNT7A; wingless-type MMTV integration site family, member 7A; K00572 wingless-type MMTV integration site family, member 7

hsa04664 Fc epsilon RI signaling pathway - Homo sapiens (human) (9)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:9846 GAB2, KIAA0571; GRB2-associated binding protein 2; K08091 growth factor receptor bound protein 2-associated protein 2
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:6850 SYK, DKFZp313N1010, FLJ25043, FLJ37489; spleen tyrosine kinase (EC:2.7.10.2); K05855 spleen tyrosine kinase [EC:2.7.10.2]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene

hsa04540 Gap junction - Homo sapiens (human) (9)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:1812 DRD1, DADR, DRD1A; dopamine receptor D1; K04144 dopamine receptor D1
hsa:1813 DRD2, D2DR, D2R; dopamine receptor D2; K04145 dopamine receptor D2
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2911 GRM1, GPRC1A, GRM1A, MGLUR1, MGLUR1A, mGlu1; glutamate receptor, metabotropic 1; K04604 metabotropic glutamate receptor 1/5
hsa:3356 HTR2A, 5-HT2A, HTR2; 5-hydroxytryptamine (serotonin) receptor 2A; K04157 5-hydroxytryptamine receptor 2
hsa:3358 HTR2C, 5-HT2C, 5-HTR2C, HTR1C; 5-hydroxytryptamine (serotonin) receptor 2C; K04157 5-hydroxytryptamine receptor 2
hsa:51807 TUBA8, TUBAL2; tubulin, alpha 8; K07374 tubulin alpha

hsa04310 Wnt signaling pathway - Homo sapiens (human) (9)



hsa:817 CAMK2D, CAMKD, DKFZp686G23119, DKFZp686I2288, MGC44911; calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:1454 CSNK1E, HCKIE, MGC10398; casein kinase 1, epsilon (EC:2.7.11.1); K08960 casein kinase 1, epsilon [EC:2.7.11.1]
hsa:2535 FZD2, Fz2, fz-2, fzE2, hFz2; frizzled homolog 2 (Drosophila); K02235 frizzled 2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:5467 PPARD, FAAR, MGC3931, NR1C2, NUC1, NUCI, NUCII, PPARB; peroxisome proliferator-activated receptor delta; K04504 peroxisome proliferator-activated receptor delta
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:83439 TCF7L1, TCF-3, TCF3; transcription factor 7-like 1 (T-cell specific, HMG-box); K04490 transcription factor 7-like 1
hsa:7482 WNT2B, WNT13, XWNT2; wingless-type MMTV integration site family, member 2B; K00182 wingless-type MMTV integration site family, member 2
hsa:7476 WNT7A; wingless-type MMTV integration site family, member 7A; K00572 wingless-type MMTV integration site family, member 7

hsa05012 Parkinson's disease - Homo sapiens (human) (9)



hsa:4535 ND1, MTND1; NADH dehydrogenase, subunit 1 (complex I); K03878 NADH dehydrogenase I subunit 1 [EC:1.6.5.3]
hsa:4538 ND4, MTND4; NADH dehydrogenase, subunit 4 (complex I); K03881 NADH dehydrogenase I subunit 4 [EC:1.6.5.3]
hsa:4539 ND4L, MTND4L; NADH dehydrogenase, subunit 4L (complex I); K03882 NADH dehydrogenase I subunit 4L [EC:1.6.5.3]
hsa:4706 NDUFAB1, ACP, FASN2A, MGC65095, SDAP; NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa; K03955 NADH dehydrogenase (ubiquinone) 1 alpha/beta subcomplex 1 [EC:1.6.5.3 1.6.99.3]
hsa:4729 NDUFV2, CI-24k; NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa (EC:1.6.5.3 1.6.99.3); K03943 NADH dehydrogenase (ubiquinone) flavoprotein 2 [EC:1.6.5.3 1.6.99.3]
hsa:6570 SLC18A1, CGAT, VAT1, VMAT1; solute carrier family 18 (vesicular monoamine), member 1; K08155 MFS transporter, DHA1 family, solute carrier family 18 (vesicular monoamine)
hsa:6571 SLC18A2, MGC120477, MGC120478, MGC26538, SVAT, SVMT, VAT2, VMAT2; solute carrier family 18 (vesicular monoamine), member 2; K08155 MFS transporter, DHA1 family, solute carrier family 18 (vesicular monoamine)
hsa:291 SLC25A4, AAC1, ANT, ANT1, PEO2, PEO3, T1; solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4; K05863 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator)
hsa:7054 TH, DYT14, DYT5b, TYH; tyrosine hydroxylase (EC:1.14.16.2); K00501 tyrosine 3-monooxygenase [EC:1.14.16.2]

hsa04720 Long-term potentiation - Homo sapiens (human) (9)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:817 CAMK2D, CAMKD, DKFZp686G23119, DKFZp686I2288, MGC44911; calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:2890 GRIA1, GLUH1, GLUR1, GLURA, GluA1, HBGR1, MGC133252; glutamate receptor, ionotropic, AMPA 1; K05197 glutamate receptor, ionotropic, AMPA 1
hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1
hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:2904 GRIN2B, MGC142178, MGC142180, NMDAR2B, NR2B, hNR3; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; K05210 glutamate receptor, ionotropic, N-methyl-D-aspartate 2B
hsa:2911 GRM1, GPRC1A, GRM1A, MGLUR1, MGLUR1A, mGlu1; glutamate receptor, metabotropic 1; K04604 metabotropic glutamate receptor 1/5
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]

hsa04670 Leukocyte transendothelial migration - Homo sapiens (human) (9)



hsa:1496 CTNNA2, CAP-R, CAPR, CT114, CTNR, DKFZp686H02198; catenin (cadherin-associated protein), alpha 2; K05691 catenin (cadherin-associated protein), alpha
hsa:3702 ITK, EMT, LYK, MGC126257, MGC126258, PSCTK2; IL2-inducible T-cell kinase (EC:2.7.10.2); K07363 IL2-inducible T-cell kinase [EC:2.7.10.2]
hsa:83700 JAM3, FLJ14529, JAM-C, JAMC; junctional adhesion molecule 3; K06785 junction adhesion molecule 3
hsa:4318 MMP9, CLG4B, GELB, MANDP2, MMP-9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35); K01403 matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]
hsa:10627 MYL12A, MLCB, MRCL3, MRLC3, MYL2B; myosin, light chain 12A, regulatory, non-sarcomeric; K12757 myosin regulatory light chain 12
hsa:103910 MYL12B, MLC-B, MRLC2; myosin, light chain 12B, regulatory; K12757 myosin regulatory light chain 12
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene

hsa04062 Chemokine signaling pathway - Homo sapiens (human) (9)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:157 ADRBK2, BARK2, GRK3; adrenergic, beta, receptor kinase 2 (EC:2.7.11.15); K00910 beta-adrenergic-receptor kinase [EC:2.7.11.15]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:2784 GNB3; guanine nucleotide binding protein (G protein), beta polypeptide 3; K07825 guanine nucleotide binding protein (G protein), beta 3
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3702 ITK, EMT, LYK, MGC126257, MGC126258, PSCTK2; IL2-inducible T-cell kinase (EC:2.7.10.2); K07363 IL2-inducible T-cell kinase [EC:2.7.10.2]
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene

hsa05016 Huntington's disease - Homo sapiens (human) (9)



hsa:627 BDNF, MGC34632; brain-derived neurotrophic factor; K04355 brain-derived neurotrophic factor
hsa:1385 CREB1, CREB, MGC9284; cAMP responsive element binding protein 1; K05870 cAMP response element-binding protein 1
hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1
hsa:2904 GRIN2B, MGC142178, MGC142180, NMDAR2B, NR2B, hNR3; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; K05210 glutamate receptor, ionotropic, N-methyl-D-aspartate 2B
hsa:2911 GRM1, GPRC1A, GRM1A, MGLUR1, MGLUR1A, mGlu1; glutamate receptor, metabotropic 1; K04604 metabotropic glutamate receptor 1/5
hsa:4706 NDUFAB1, ACP, FASN2A, MGC65095, SDAP; NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa; K03955 NADH dehydrogenase (ubiquinone) 1 alpha/beta subcomplex 1 [EC:1.6.5.3 1.6.99.3]
hsa:4729 NDUFV2, CI-24k; NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa (EC:1.6.5.3 1.6.99.3); K03943 NADH dehydrogenase (ubiquinone) flavoprotein 2 [EC:1.6.5.3 1.6.99.3]
hsa:291 SLC25A4, AAC1, ANT, ANT1, PEO2, PEO3, T1; solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4; K05863 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator)
hsa:6648 SOD2, IPOB, MNSOD, MVCD6; superoxide dismutase 2, mitochondrial (EC:1.15.1.1); K04564 superoxide dismutase, Fe-Mn family [EC:1.15.1.1]

hsa05410 Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human) (9)



hsa:1636 ACE, ACE1, CD143, DCP, DCP1, MGC26566, MVCD3; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1); K01283 peptidyl-dipeptidase A [EC:3.4.15.1]
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:783 CACNB2, CACNLB2, CAVB2, FLJ23743, MYSB; calcium channel, voltage-dependent, beta 2 subunit; K04863 voltage-dependent calcium channel beta-2
hsa:27091 CACNG5, MGC126656, MGC126682; calcium channel, voltage-dependent, gamma subunit 5; K04870 voltage-dependent calcium channel gamma-5
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:6262 RYR2, ARVC2, ARVD2, VTSIP; ryanodine receptor 2 (cardiac); K04962 ryanodine receptor 2
hsa:6444 SGCD, 35DAG, CMD1L, DAGD, MGC22567, SG-delta, SGCDP, SGD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein); K12563 delta-sarcoglycan
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05414 Dilated cardiomyopathy - Homo sapiens (human) (9)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:783 CACNB2, CACNLB2, CAVB2, FLJ23743, MYSB; calcium channel, voltage-dependent, beta 2 subunit; K04863 voltage-dependent calcium channel beta-2
hsa:27091 CACNG5, MGC126656, MGC126682; calcium channel, voltage-dependent, gamma subunit 5; K04870 voltage-dependent calcium channel gamma-5
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:6262 RYR2, ARVC2, ARVD2, VTSIP; ryanodine receptor 2 (cardiac); K04962 ryanodine receptor 2
hsa:6444 SGCD, 35DAG, CMD1L, DAGD, MGC22567, SG-delta, SGCDP, SGD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein); K12563 delta-sarcoglycan
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04976 Bile secretion - Homo sapiens (human) (8)



hsa:5243 ABCB1, ABC20, CD243, CLCS, GP170, MDR1, MGC163296, P-GP, PGY1; ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44); K05658 ATP-binding cassette, subfamily B (MDR/TAP), member 1
hsa:8647 ABCB11, ABC16, BRIC2, BSEP, PFIC-2, PFIC2, PGY4, SPGP; ATP-binding cassette, sub-family B (MDR/TAP), member 11; K05664 ATP-binding cassette, subfamily B (MDR/TAP), member 11
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:361 AQP4, HMIWC2, MGC22454, MIWC; aquaporin 4; K09866 aquaporin-4
hsa:476 ATP1A1, MGC3285, MGC51750; ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:477 ATP1A2, FHM2, MGC59864, MHP2; ATPase, Na+/K+ transporting, alpha 2 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:478 ATP1A3, DYT12, MGC13276, RDP; ATPase, Na+/K+ transporting, alpha 3 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]

hsa04012 ErbB signaling pathway - Homo sapiens (human) (8)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:817 CAMK2D, CAMKD, DKFZp686G23119, DKFZp686I2288, MGC44911; calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2066 ERBB4, HER4, MGC138404, p180erbB4; v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) (EC:2.7.10.1); K05085 receptor tyrosine-protein kinase erbB-4 [EC:2.7.10.1]
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3084 NRG1, ARIA, GGF, GGF2, HGL, HRG, HRG1, HRGA, MST131, NDF, SMDF; neuregulin 1; K05455 neuregulin 1
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]

hsa05014 Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human) (8)



hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:2890 GRIA1, GLUH1, GLUR1, GLURA, GluA1, HBGR1, MGC133252; glutamate receptor, ionotropic, AMPA 1; K05197 glutamate receptor, ionotropic, AMPA 1
hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1
hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:2904 GRIN2B, MGC142178, MGC142180, NMDAR2B, NR2B, hNR3; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; K05210 glutamate receptor, ionotropic, N-methyl-D-aspartate 2B
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04530 Tight junction - Homo sapiens (human) (8)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1496 CTNNA2, CAP-R, CAPR, CT114, CTNR, DKFZp686H02198; catenin (cadherin-associated protein), alpha 2; K05691 catenin (cadherin-associated protein), alpha
hsa:83700 JAM3, FLJ14529, JAM-C, JAMC; junctional adhesion molecule 3; K06785 junction adhesion molecule 3
hsa:3993 LLGL2, HGL, LGL2; lethal giant larvae homolog 2 (Drosophila); K06094 lethal giant larvae
hsa:10627 MYL12A, MLCB, MRCL3, MRLC3, MYL2B; myosin, light chain 12A, regulatory, non-sarcomeric; K12757 myosin regulatory light chain 12
hsa:103910 MYL12B, MLC-B, MRLC2; myosin, light chain 12B, regulatory; K12757 myosin regulatory light chain 12
hsa:5522 PPP2R2C, B55-GAMMA, IMYPNO, IMYPNO1, MGC33570, PR52, PR55G; protein phosphatase 2, regulatory subunit B, gamma (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:9218 VAPA, MGC3745, VAP-33, VAP-A, VAP33, hVAP-33; VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa; K06096 vesicle-associated membrane protein-associated protein A

hsa04710 Circadian rhythm - mammal - Homo sapiens (human) (8)



hsa:406 ARNTL, BMAL1, BMAL1c, JAP3, MGC47515, MOP3, PASD3, TIC, bHLHe5; aryl hydrocarbon receptor nuclear translocator-like; K02296 aryl hydrocarbon receptor nuclear translocator-like protein 1
hsa:9575 CLOCK, KAT13D, KIAA0334, bHLHe8; clock homolog (mouse) (EC:2.3.1.48); K02223 circadian locomoter output cycles kaput protein [EC:2.3.1.48]
hsa:1408 CRY2, FLJ10332, HCRY2, KIAA0658, PHLL2; cryptochrome 2 (photolyase-like); K02295 cryptochrome
hsa:1454 CSNK1E, HCKIE, MGC10398; casein kinase 1, epsilon (EC:2.7.11.1); K08960 casein kinase 1, epsilon [EC:2.7.11.1]
hsa:4862 NPAS2, FLJ23138, MGC71151, MOP4, PASD4, bHLHe9; neuronal PAS domain protein 2; K09026 neuronal PAS domain-containing protein 2
hsa:9572 NR1D1, EAR1, THRA1, THRAL, ear-1, hRev; nuclear receptor subfamily 1, group D, member 1; K03728 nuclear receptor subfamily 1 group D member 1
hsa:8863 PER3, GIG13; period homolog 3 (Drosophila); K02633 period circadian protein
hsa:6096 RORB, NR1F2, ROR-BETA, RZR-BETA, RZRB, bA133M9.1; RAR-related orphan receptor B; K08533 RAR-related orphan receptor beta

hsa05215 Prostate cancer - Homo sapiens (human) (8)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:1385 CREB1, CREB, MGC9284; cAMP responsive element binding protein 1; K05870 cAMP response element-binding protein 1
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:7184 HSP90B1, ECGP, GP96, GRP94, TRA1; heat shock protein 90kDa beta (Grp94), member 1; K09487 heat shock protein 90kDa beta
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:83439 TCF7L1, TCF-3, TCF3; transcription factor 7-like 1 (T-cell specific, HMG-box); K04490 transcription factor 7-like 1

hsa04972 Pancreatic secretion - Homo sapiens (human) (8)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:476 ATP1A1, MGC3285, MGC51750; ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:477 ATP1A2, FHM2, MGC59864, MHP2; ATPase, Na+/K+ transporting, alpha 2 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:478 ATP1A3, DYT12, MGC13276, RDP; ATPase, Na+/K+ transporting, alpha 3 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:1361 CPB2, CPU, PCPB, TAFI; carboxypeptidase B2 (plasma) (EC:3.4.17.20); K01300 carboxypeptidase B2 [EC:3.4.17.20]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:6262 RYR2, ARVC2, ARVD2, VTSIP; ryanodine receptor 2 (cardiac); K04962 ryanodine receptor 2

hsa04971 Gastric acid secretion - Homo sapiens (human) (8)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:476 ATP1A1, MGC3285, MGC51750; ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:477 ATP1A2, FHM2, MGC59864, MHP2; ATPase, Na+/K+ transporting, alpha 2 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:478 ATP1A3, DYT12, MGC13276, RDP; ATPase, Na+/K+ transporting, alpha 3 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:817 CAMK2D, CAMKD, DKFZp686G23119, DKFZp686I2288, MGC44911; calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:115111 SLC26A7, MGC126268, SUT2; solute carrier family 26, member 7; K13962 solute carrier family 26 (sulfate anion transporter), member 7
hsa:6750 SST, SMST; somatostatin; K05237 somatostatin

hsa04650 Natural killer cell mediated cytotoxicity - Homo sapiens (human) (8)



hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:6850 SYK, DKFZp313N1010, FLJ25043, FLJ37489; spleen tyrosine kinase (EC:2.7.10.2); K05855 spleen tyrosine kinase [EC:2.7.10.2]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene

hsa04810 Regulation of actin cytoskeleton - Homo sapiens (human) (7)



hsa:624 BDKRB2, B2R, BK-2, BK2, BKR2, BRB2, DKFZp686O088; bradykinin receptor B2; K03916 bradykinin receptor B2
hsa:1129 CHRM2, FLJ43243, HM2, MGC120006, MGC120007; cholinergic receptor, muscarinic 2; K04130 muscarinic acetylcholine receptor M2
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:10627 MYL12A, MLCB, MRCL3, MRLC3, MYL2B; myosin, light chain 12A, regulatory, non-sarcomeric; K12757 myosin regulatory light chain 12
hsa:103910 MYL12B, MLC-B, MRLC2; myosin, light chain 12B, regulatory; K12757 myosin regulatory light chain 12
hsa:375189 PFN4; profilin family, member 4; K05759 profilin
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene

hsa05144 Malaria - Homo sapiens (human) (7)



hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:6383 SDC2, HSPG, HSPG1, SYND2; syndecan 2; K06257 syndecan
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human) (7)



hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:783 CACNB2, CACNLB2, CAVB2, FLJ23743, MYSB; calcium channel, voltage-dependent, beta 2 subunit; K04863 voltage-dependent calcium channel beta-2
hsa:27091 CACNG5, MGC126656, MGC126682; calcium channel, voltage-dependent, gamma subunit 5; K04870 voltage-dependent calcium channel gamma-5
hsa:1496 CTNNA2, CAP-R, CAPR, CT114, CTNR, DKFZp686H02198; catenin (cadherin-associated protein), alpha 2; K05691 catenin (cadherin-associated protein), alpha
hsa:6262 RYR2, ARVC2, ARVD2, VTSIP; ryanodine receptor 2 (cardiac); K04962 ryanodine receptor 2
hsa:6444 SGCD, 35DAG, CMD1L, DAGD, MGC22567, SG-delta, SGCDP, SGD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein); K12563 delta-sarcoglycan
hsa:83439 TCF7L1, TCF-3, TCF3; transcription factor 7-like 1 (T-cell specific, HMG-box); K04490 transcription factor 7-like 1

hsa04360 Axon guidance - Homo sapiens (human) (7)



hsa:1808 DPYSL2, CRMP2, DHPRP2, DRP-2, DRP2; dihydropyrimidinase-like 2; K07528 dihydropyrimidinase-like 2
hsa:1946 EFNA5, AF1, EFL5, EPLG7, GLC1M, LERK7, RAGS; ephrin-A5; K05462 ephrin-A
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:57689 LRRC4C, KIAA1580, NGL-1, NGL1; leucine rich repeat containing 4C; K07523 netrin-G1 ligand
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:6586 SLIT3, FLJ10764, MEGF5, SLIL2, SLIT1, Slit-3, slit2; slit homolog 3 (Drosophila); K06850 slit 3

hsa05145 Toxoplasmosis - Homo sapiens (human) (7)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3909 LAMA3, BM600, E170, LAMNA, LOCS, lama3a; laminin, alpha 3; K06240 laminin, alpha 3/5
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05214 Glioma - Homo sapiens (human) (7)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:817 CAMK2D, CAMKD, DKFZp686G23119, DKFZp686I2288, MGC44911; calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:1029 CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); K06621 cyclin-dependent kinase inhibitor 2A
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]

hsa04070 Phosphatidylinositol signaling system - Homo sapiens (human) (7)



hsa:160851 DGKH, DGKeta, DKFZp761I1510; diacylglycerol kinase, eta (EC:2.7.1.107); K00901 diacylglycerol kinase [EC:2.7.1.107]
hsa:3613 IMPA2; inositol(myo)-1(or 4)-monophosphatase 2 (EC:3.1.3.25); K01092 myo-inositol-1(or 4)-monophosphatase [EC:3.1.3.25]
hsa:5289 PIK3C3, MGC61518, VPS34, hVps34; phosphoinositide-3-kinase, class 3 (EC:2.7.1.137); K00914 phosphatidylinositol 3-kinase [EC:2.7.1.137]
hsa:51196 PLCE1, FLJ23659, KIAA1516, MGC167842, NPHS3, PLCE, PPLC; phospholipase C, epsilon 1 (EC:3.1.4.11); K05860 phospholipase C, epsilon
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:8867 SYNJ1, INPP5G; synaptojanin 1 (EC:3.1.3.36); K01099 phosphatidylinositol-bisphosphatase [EC:3.1.3.36]

hsa04260 Cardiac muscle contraction - Homo sapiens (human) (7)



hsa:476 ATP1A1, MGC3285, MGC51750; ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:477 ATP1A2, FHM2, MGC59864, MHP2; ATPase, Na+/K+ transporting, alpha 2 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:478 ATP1A3, DYT12, MGC13276, RDP; ATPase, Na+/K+ transporting, alpha 3 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:783 CACNB2, CACNLB2, CAVB2, FLJ23743, MYSB; calcium channel, voltage-dependent, beta 2 subunit; K04863 voltage-dependent calcium channel beta-2
hsa:27091 CACNG5, MGC126656, MGC126682; calcium channel, voltage-dependent, gamma subunit 5; K04870 voltage-dependent calcium channel gamma-5
hsa:6262 RYR2, ARVC2, ARVD2, VTSIP; ryanodine receptor 2 (cardiac); K04962 ryanodine receptor 2

hsa05146 Amoebiasis - Homo sapiens (human) (7)



hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3909 LAMA3, BM600, E170, LAMNA, LOCS, lama3a; laminin, alpha 3; K06240 laminin, alpha 3/5
hsa:4583 MUC2, MLP, MUC-2, SMUC; mucin 2, oligomeric mucus/gel-forming; K10955 intestinal mucin-2
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04912 GnRH signaling pathway - Homo sapiens (human) (6)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:817 CAMK2D, CAMKD, DKFZp686G23119, DKFZp686I2288, MGC44911; calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa04370 VEGF signaling pathway - Homo sapiens (human) (6)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:4846 NOS3, ECNOS, eNOS; nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39); K13242 nitric-oxide synthase, endothelial [EC:1.14.13.39]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]

hsa04514 Cell adhesion molecules (CAMs) - Homo sapiens (human) (6)



hsa:26047 CNTNAP2, AUTS15, CASPR2, CDFE, DKFZp781D1846, NRXN4, PTHSL1; contactin associated protein-like 2; K07380 contactin associated protein-like 2
hsa:1493 CTLA4, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, ICOS, IDDM12; cytotoxic T-lymphocyte-associated protein 4; K06538 cytotoxic T-lymphocyte-associated protein 4
hsa:83700 JAM3, FLJ14529, JAM-C, JAMC; junctional adhesion molecule 3; K06785 junction adhesion molecule 3
hsa:4684 NCAM1, CD56, MSK39, NCAM; neural cell adhesion molecule 1 (EC:2.7.11.1); K06491 neural cell adhesion molecule
hsa:9378 NRXN1, DKFZp313P2036, FLJ35941, Hs.22998, KIAA0578, PTHSL2; neurexin 1; K07377 neurexin
hsa:6383 SDC2, HSPG, HSPG1, SYND2; syndecan 2; K06257 syndecan

hsa05223 Non-small cell lung cancer - Homo sapiens (human) (6)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1029 CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); K06621 cyclin-dependent kinase inhibitor 2A
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:6258 RXRG, NR2B3, RXRC; retinoid X receptor, gamma; K08526 retinoid X receptor gamma

hsa00562 Inositol phosphate metabolism - Homo sapiens (human) (6)



hsa:3613 IMPA2; inositol(myo)-1(or 4)-monophosphatase 2 (EC:3.1.3.25); K01092 myo-inositol-1(or 4)-monophosphatase [EC:3.1.3.25]
hsa:5289 PIK3C3, MGC61518, VPS34, hVps34; phosphoinositide-3-kinase, class 3 (EC:2.7.1.137); K00914 phosphatidylinositol 3-kinase [EC:2.7.1.137]
hsa:51196 PLCE1, FLJ23659, KIAA1516, MGC167842, NPHS3, PLCE, PPLC; phospholipase C, epsilon 1 (EC:3.1.4.11); K05860 phospholipase C, epsilon
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:8867 SYNJ1, INPP5G; synaptojanin 1 (EC:3.1.3.36); K01099 phosphatidylinositol-bisphosphatase [EC:3.1.3.36]

hsa04666 Fc gamma R-mediated phagocytosis - Homo sapiens (human) (6)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:9846 GAB2, KIAA0571; GRB2-associated binding protein 2; K08091 growth factor receptor bound protein 2-associated protein 2
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:6850 SYK, DKFZp313N1010, FLJ25043, FLJ37489; spleen tyrosine kinase (EC:2.7.10.2); K05855 spleen tyrosine kinase [EC:2.7.10.2]
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene

hsa04210 Apoptosis - Homo sapiens (human) (6)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:1439 CSF2RB, CD131, CDw131, IL3RB, IL5RB; colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); K04738 cytokine receptor common subunit beta
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04144 Endocytosis - Homo sapiens (human) (6)



hsa:157 ADRBK2, BARK2, GRK3; adrenergic, beta, receptor kinase 2 (EC:2.7.11.15); K00910 beta-adrenergic-receptor kinase [EC:2.7.11.15]
hsa:57132 CHMP1B, C10orf2, C18-ORF2, C18orf2, CHMP1.5, Vps46-2, Vps46B; chromatin modifying protein 1B; K12197 charged multivesicular body protein 1
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2066 ERBB4, HER4, MGC138404, p180erbB4; v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) (EC:2.7.10.1); K05085 receptor tyrosine-protein kinase erbB-4 [EC:2.7.10.1]
hsa:3560 IL2RB, CD122, P70-75; interleukin 2 receptor, beta; K05069 interleukin 2 receptor beta
hsa:3815 KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]

hsa04970 Salivary secretion - Homo sapiens (human) (6)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:476 ATP1A1, MGC3285, MGC51750; ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:477 ATP1A2, FHM2, MGC59864, MHP2; ATPase, Na+/K+ transporting, alpha 2 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:478 ATP1A3, DYT12, MGC13276, RDP; ATPase, Na+/K+ transporting, alpha 3 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]

hsa04662 B cell receptor signaling pathway - Homo sapiens (human) (6)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:6850 SYK, DKFZp313N1010, FLJ25043, FLJ37489; spleen tyrosine kinase (EC:2.7.10.2); K05855 spleen tyrosine kinase [EC:2.7.10.2]
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene

hsa04114 Oocyte meiosis - Homo sapiens (human) (6)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:817 CAMK2D, CAMKD, DKFZp686G23119, DKFZp686I2288, MGC44911; calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:7533 YWHAH, YWHA1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein

hsa04730 Long-term depression - Homo sapiens (human) (6)



hsa:2781 GNAZ; guanine nucleotide binding protein (G protein), alpha z polypeptide; K04535 guanine nucleotide binding protein (G protein), alpha z polypeptide
hsa:2890 GRIA1, GLUH1, GLUR1, GLURA, GluA1, HBGR1, MGC133252; glutamate receptor, ionotropic, AMPA 1; K05197 glutamate receptor, ionotropic, AMPA 1
hsa:2911 GRM1, GPRC1A, GRM1A, MGLUR1, MGLUR1A, mGlu1; glutamate receptor, metabotropic 1; K04604 metabotropic glutamate receptor 1/5
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa04630 Jak-STAT signaling pathway - Homo sapiens (human) (6)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1439 CSF2RB, CD131, CDw131, IL3RB, IL5RB; colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); K04738 cytokine receptor common subunit beta
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3560 IL2RB, CD122, P70-75; interleukin 2 receptor, beta; K05069 interleukin 2 receptor beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6

hsa00190 Oxidative phosphorylation - Homo sapiens (human) (6)



hsa:9114 ATP6V0D1, ATP6D, ATP6DV, FLJ43534, P39, VATX, VMA6, VPATPD; ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 (EC:3.6.3.14); K02146 V-type H+-transporting ATPase subunit AC39 [EC:3.6.3.14]
hsa:4535 ND1, MTND1; NADH dehydrogenase, subunit 1 (complex I); K03878 NADH dehydrogenase I subunit 1 [EC:1.6.5.3]
hsa:4538 ND4, MTND4; NADH dehydrogenase, subunit 4 (complex I); K03881 NADH dehydrogenase I subunit 4 [EC:1.6.5.3]
hsa:4539 ND4L, MTND4L; NADH dehydrogenase, subunit 4L (complex I); K03882 NADH dehydrogenase I subunit 4L [EC:1.6.5.3]
hsa:4706 NDUFAB1, ACP, FASN2A, MGC65095, SDAP; NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa; K03955 NADH dehydrogenase (ubiquinone) 1 alpha/beta subcomplex 1 [EC:1.6.5.3 1.6.99.3]
hsa:4729 NDUFV2, CI-24k; NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa (EC:1.6.5.3 1.6.99.3); K03943 NADH dehydrogenase (ubiquinone) flavoprotein 2 [EC:1.6.5.3 1.6.99.3]

hsa04145 Phagosome - Homo sapiens (human) (6)



hsa:9114 ATP6V0D1, ATP6D, ATP6DV, FLJ43534, P39, VATX, VMA6, VPATPD; ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 (EC:3.6.3.14); K02146 V-type H+-transporting ATPase subunit AC39 [EC:3.6.3.14]
hsa:81035 COLEC12, CLP1, NSR2, SCARA4, SRCL; collectin sub-family member 12; K10062 collectin sub-family member 12
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:5289 PIK3C3, MGC61518, VPS34, hVps34; phosphoinositide-3-kinase, class 3 (EC:2.7.1.137); K00914 phosphatidylinositol 3-kinase [EC:2.7.1.137]
hsa:22925 PLA2R1, CLEC13C, PLA2-R, PLA2G1R, PLA2IR, PLA2R; phospholipase A2 receptor 1, 180kDa; K06560 mannose receptor, C type
hsa:51807 TUBA8, TUBAL2; tubulin, alpha 8; K07374 tubulin alpha

hsa05110 Vibrio cholerae infection - Homo sapiens (human) (5)



hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:9114 ATP6V0D1, ATP6D, ATP6DV, FLJ43534, P39, VATX, VMA6, VPATPD; ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 (EC:3.6.3.14); K02146 V-type H+-transporting ATPase subunit AC39 [EC:3.6.3.14]
hsa:4583 MUC2, MLP, MUC-2, SMUC; mucin 2, oligomeric mucus/gel-forming; K10955 intestinal mucin-2
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]

hsa04340 Hedgehog signaling pathway - Homo sapiens (human) (5)



hsa:654 BMP6, VGR, VGR1; bone morphogenetic protein 6; K04663 bone morphogenetic protein 5/6/7/8
hsa:1454 CSNK1E, HCKIE, MGC10398; casein kinase 1, epsilon (EC:2.7.11.1); K08960 casein kinase 1, epsilon [EC:2.7.11.1]
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:7482 WNT2B, WNT13, XWNT2; wingless-type MMTV integration site family, member 2B; K00182 wingless-type MMTV integration site family, member 2
hsa:7476 WNT7A; wingless-type MMTV integration site family, member 7A; K00572 wingless-type MMTV integration site family, member 7

hsa04973 Carbohydrate digestion and absorption - Homo sapiens (human) (5)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:476 ATP1A1, MGC3285, MGC51750; ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:477 ATP1A2, FHM2, MGC59864, MHP2; ATPase, Na+/K+ transporting, alpha 2 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:478 ATP1A3, DYT12, MGC13276, RDP; ATPase, Na+/K+ transporting, alpha 3 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:3099 HK2, DKFZp686M1669, HKII, HXK2; hexokinase 2 (EC:2.7.1.1); K00844 hexokinase [EC:2.7.1.1]

hsa05120 Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human) (5)



hsa:9114 ATP6V0D1, ATP6D, ATP6DV, FLJ43534, P39, VATX, VMA6, VPATPD; ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 (EC:3.6.3.14); K02146 V-type H+-transporting ATPase subunit AC39 [EC:3.6.3.14]
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:83700 JAM3, FLJ14529, JAM-C, JAMC; junctional adhesion molecule 3; K06785 junction adhesion molecule 3
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]

hsa00330 Arginine and proline metabolism - Homo sapiens (human) (5)



hsa:217 ALDH2, ALDH-E2, ALDHI, ALDM, MGC1806; aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3); K00128 aldehyde dehydrogenase (NAD+) [EC:1.2.1.3]
hsa:1610 DAO, DAAO, DAMOX, MGC35381, OXDA; D-amino-acid oxidase (EC:1.4.3.3); K00273 D-amino-acid oxidase [EC:1.4.3.3]
hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:4846 NOS3, ECNOS, eNOS; nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39); K13242 nitric-oxide synthase, endothelial [EC:1.14.13.39]

hsa04612 Antigen processing and presentation - Homo sapiens (human) (5)



hsa:1385 CREB1, CREB, MGC9284; cAMP responsive element binding protein 1; K05870 cAMP response element-binding protein 1
hsa:3308 HSPA4, APG-2, HS24/P52, MGC131852, RY, hsp70, hsp70RY; heat shock 70kDa protein 4; K09489 heat shock 70kDa protein 4
hsa:3309 HSPA5, BIP, FLJ26106, GRP78, MIF2; heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa); K09490 heat shock 70kDa protein 5
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa00380 Tryptophan metabolism - Homo sapiens (human) (5)



hsa:217 ALDH2, ALDH-E2, ALDHI, ALDM, MGC1806; aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3); K00128 aldehyde dehydrogenase (NAD+) [EC:1.2.1.3]
hsa:1644 DDC, AADC; dopa decarboxylase (aromatic L-amino acid decarboxylase) (EC:4.1.1.28); K01593 aromatic-L-amino-acid decarboxylase [EC:4.1.1.28]
hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]
hsa:6999 TDO2, TDO, TPH2, TRPO; tryptophan 2,3-dioxygenase (EC:1.13.11.11); K00453 tryptophan 2,3-dioxygenase [EC:1.13.11.11]
hsa:121278 TPH2, ADHD7, FLJ37295, MGC138871, MGC138872, NTPH; tryptophan hydroxylase 2 (EC:1.14.16.4); K00502 tryptophan 5-monooxygenase [EC:1.14.16.4]

hsa04520 Adherens junction - Homo sapiens (human) (5)



hsa:1496 CTNNA2, CAP-R, CAPR, CT114, CTNR, DKFZp686H02198; catenin (cadherin-associated protein), alpha 2; K05691 catenin (cadherin-associated protein), alpha
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:5787 PTPRB, DKFZp686E2262, DKFZp686H15164, FLJ44133, HPTP-BETA, HPTPB, MGC142023, MGC59935, PTPB, R-PTP-BETA, VEPTP; protein tyrosine phosphatase, receptor type, B (EC:3.1.3.48); K05694 protein tyrosine phosphatase, receptor type, B [EC:3.1.3.48]
hsa:83439 TCF7L1, TCF-3, TCF3; transcription factor 7-like 1 (T-cell specific, HMG-box); K04490 transcription factor 7-like 1

hsa05213 Endometrial cancer - Homo sapiens (human) (5)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1496 CTNNA2, CAP-R, CAPR, CT114, CTNR, DKFZp686H02198; catenin (cadherin-associated protein), alpha 2; K05691 catenin (cadherin-associated protein), alpha
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:83439 TCF7L1, TCF-3, TCF3; transcription factor 7-like 1 (T-cell specific, HMG-box); K04490 transcription factor 7-like 1

hsa05143 African trypanosomiasis - Homo sapiens (human) (5)



hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04621 NOD-like receptor signaling pathway - Homo sapiens (human) (5)



hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:7184 HSP90B1, ECGP, GP96, GRP94, TRA1; heat shock protein 90kDa beta (Grp94), member 1; K09487 heat shock protein 90kDa beta
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04940 Type I diabetes mellitus - Homo sapiens (human) (5)



hsa:2571 GAD1, FLJ45882, GAD, SCP; glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15); K01580 glutamate decarboxylase [EC:4.1.1.15]
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:5799 PTPRN2, IA-2beta, IAR, ICAAR, PTPRP; protein tyrosine phosphatase, receptor type, N polypeptide 2 (EC:3.1.3.48); K07817 protein tyrosine phosphatase, receptor type, N [EC:3.1.3.48]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04914 Progesterone-mediated oocyte maturation - Homo sapiens (human) (5)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:994 CDC25B; cell division cycle 25 homolog B (S. pombe) (EC:3.1.3.48); K05866 cell division cycle 25B [EC:3.1.3.48]
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1

hsa04141 Protein processing in endoplasmic reticulum - Homo sapiens (human) (5)



hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:7184 HSP90B1, ECGP, GP96, GRP94, TRA1; heat shock protein 90kDa beta (Grp94), member 1; K09487 heat shock protein 90kDa beta
hsa:3309 HSPA5, BIP, FLJ26106, GRP78, MIF2; heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa); K09490 heat shock 70kDa protein 5
hsa:7466 WFS1, FLJ51211, WFRS, WFS; Wolfram syndrome 1 (wolframin); K14020 wolfamin
hsa:7494 XBP1, TREB5, XBP2; X-box binding protein 1; K09027 X box-binding protein 1

hsa05322 Systemic lupus erythematosus - Homo sapiens (human) (5)



hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:2904 GRIN2B, MGC142178, MGC142180, NMDAR2B, NR2B, hNR3; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; K05210 glutamate receptor, ionotropic, N-methyl-D-aspartate 2B
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05020 Prion diseases - Homo sapiens (human) (5)



hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:3309 HSPA5, BIP, FLJ26106, GRP78, MIF2; heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa); K09490 heat shock 70kDa protein 5
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:4684 NCAM1, CD56, MSK39, NCAM; neural cell adhesion molecule 1 (EC:2.7.11.1); K06491 neural cell adhesion molecule

hsa05217 Basal cell carcinoma - Homo sapiens (human) (5)



hsa:2535 FZD2, Fz2, fz-2, fzE2, hFz2; frizzled homolog 2 (Drosophila); K02235 frizzled 2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:83439 TCF7L1, TCF-3, TCF3; transcription factor 7-like 1 (T-cell specific, HMG-box); K04490 transcription factor 7-like 1
hsa:7482 WNT2B, WNT13, XWNT2; wingless-type MMTV integration site family, member 2B; K00182 wingless-type MMTV integration site family, member 2
hsa:7476 WNT7A; wingless-type MMTV integration site family, member 7A; K00572 wingless-type MMTV integration site family, member 7

hsa05160 Hepatitis C - Homo sapiens (human) (5)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:5522 PPP2R2C, B55-GAMMA, IMYPNO, IMYPNO1, MGC33570, PR52, PR55G; protein phosphatase 2, regulatory subunit B, gamma (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04640 Hematopoietic cell lineage - Homo sapiens (human) (4)

hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3815 KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa00590 Arachidonic acid metabolism - Homo sapiens (human) (4)



hsa:239 ALOX12, 12-LOX, 12S-LOX, LOG12; arachidonate 12-lipoxygenase (EC:1.13.11.31); K00458 arachidonate 12-lipoxygenase [EC:1.13.11.31]
hsa:2878 GPX3, GPx-P, GSHPx-3, GSHPx-P; glutathione peroxidase 3 (plasma) (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5740 PTGIS, CYP8, CYP8A1, MGC126858, MGC126860, PGIS, PTGI; prostaglandin I2 (prostacyclin) synthase (EC:5.3.99.4); K01831 cytochrome P450, family 8, subfamily A (Prostacyclin synthase) [EC:5.3.99.4]

hsa05221 Acute myeloid leukemia - Homo sapiens (human) (4)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:3815 KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
hsa:5467 PPARD, FAAR, MGC3931, NR1C2, NUC1, NUCI, NUCII, PPARB; peroxisome proliferator-activated receptor delta; K04504 peroxisome proliferator-activated receptor delta
hsa:83439 TCF7L1, TCF-3, TCF3; transcription factor 7-like 1 (T-cell specific, HMG-box); K04490 transcription factor 7-like 1

hsa05210 Colorectal cancer - Homo sapiens (human) (4)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:83439 TCF7L1, TCF-3, TCF3; transcription factor 7-like 1 (T-cell specific, HMG-box); K04490 transcription factor 7-like 1

hsa04962 Vasopressin-regulated water reabsorption - Homo sapiens (human) (4)



hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:361 AQP4, HMIWC2, MGC22454, MIWC; aquaporin 4; K09866 aquaporin-4
hsa:1385 CREB1, CREB, MGC9284; cAMP responsive element binding protein 1; K05870 cAMP response element-binding protein 1
hsa:84516 DCTN5, MGC3248; dynactin 5 (p25); K10427 dynactin 5

hsa04110 Cell cycle - Homo sapiens (human) (4)



hsa:994 CDC25B; cell division cycle 25 homolog B (S. pombe) (EC:3.1.3.48); K05866 cell division cycle 25B [EC:3.1.3.48]
hsa:1029 CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); K06621 cyclin-dependent kinase inhibitor 2A
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:7533 YWHAH, YWHA1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein

hsa05218 Melanoma - Homo sapiens (human) (4)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1029 CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); K06621 cyclin-dependent kinase inhibitor 2A
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1

hsa04974 Protein digestion and absorption - Homo sapiens (human) (4)



hsa:476 ATP1A1, MGC3285, MGC51750; ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:477 ATP1A2, FHM2, MGC59864, MHP2; ATPase, Na+/K+ transporting, alpha 2 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:478 ATP1A3, DYT12, MGC13276, RDP; ATPase, Na+/K+ transporting, alpha 3 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:1361 CPB2, CPU, PCPB, TAFI; carboxypeptidase B2 (plasma) (EC:3.4.17.20); K01300 carboxypeptidase B2 [EC:3.4.17.20]

hsa00230 Purine metabolism - Homo sapiens (human) (4)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:5142 PDE4B, DKFZp686F2182, DPDE4, MGC126529, PDE4B5, PDEIVB; phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17); K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5427 POLE2, DPE2; polymerase (DNA directed), epsilon 2 (p59 subunit) (EC:2.7.7.7); K02325 DNA polymerase epsilon subunit 2 [EC:2.7.7.7]

hsa04960 Aldosterone-regulated sodium reabsorption - Homo sapiens (human) (4)



hsa:476 ATP1A1, MGC3285, MGC51750; ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:477 ATP1A2, FHM2, MGC59864, MHP2; ATPase, Na+/K+ transporting, alpha 2 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:478 ATP1A3, DYT12, MGC13276, RDP; ATPase, Na+/K+ transporting, alpha 3 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1

hsa05222 Small cell lung cancer - Homo sapiens (human) (4)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:3909 LAMA3, BM600, E170, LAMNA, LOCS, lama3a; laminin, alpha 3; K06240 laminin, alpha 3/5
hsa:6258 RXRG, NR2B3, RXRC; retinoid X receptor, gamma; K08526 retinoid X receptor gamma

hsa05140 Leishmaniasis - Homo sapiens (human) (4)



hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04742 Taste transduction - Homo sapiens (human) (4)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:774 CACNA1B, BIII, CACNL1A5, CACNN, Cav2.2; calcium channel, voltage-dependent, N type, alpha 1B subunit; K04849 voltage-dependent calcium channel N type alpha-1B
hsa:2784 GNB3; guanine nucleotide binding protein (G protein), beta polypeptide 3; K07825 guanine nucleotide binding protein (G protein), beta 3
hsa:2914 GRM4, GPRC1D, MGC177594, MGLUR4, mGlu4; glutamate receptor, metabotropic 4; K04607 metabotropic glutamate receptor 4

hsa02010 ABC transporters - Homo sapiens (human) (4)



hsa:154664 ABCA13, DKFZp313D2411, FLJ16398, FLJ33876, FLJ33951; ATP-binding cassette, sub-family A (ABC1), member 13; K05647 ATP binding cassette, subfamily A (ABC1), member 13
hsa:23460 ABCA6, EST155051, FLJ43498; ATP-binding cassette, sub-family A (ABC1), member 6; K05649 ATP-binding cassette, subfamily A (ABC1), member 6
hsa:5243 ABCB1, ABC20, CD243, CLCS, GP170, MDR1, MGC163296, P-GP, PGY1; ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44); K05658 ATP-binding cassette, subfamily B (MDR/TAP), member 1
hsa:8647 ABCB11, ABC16, BRIC2, BSEP, PFIC-2, PFIC2, PGY4, SPGP; ATP-binding cassette, sub-family B (MDR/TAP), member 11; K05664 ATP-binding cassette, subfamily B (MDR/TAP), member 11

hsa05332 Graft-versus-host disease - Homo sapiens (human) (4)



hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04620 Toll-like receptor signaling pathway - Homo sapiens (human) (4)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa03320 PPAR signaling pathway - Homo sapiens (human) (4)



hsa:2170 FABP3, FABP11, H-FABP, MDGI, O-FABP; fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor); K08752 fatty acid-binding protein 3, muscle and heart
hsa:2173 FABP7, B-FABP, BLBP, DKFZp547J2313, FABPB, MRG; fatty acid binding protein 7, brain; K08756 fatty acid-binding protein 7, brain
hsa:5467 PPARD, FAAR, MGC3931, NR1C2, NUC1, NUCI, NUCII, PPARB; peroxisome proliferator-activated receptor delta; K04504 peroxisome proliferator-activated receptor delta
hsa:6258 RXRG, NR2B3, RXRC; retinoid X receptor, gamma; K08526 retinoid X receptor gamma

hsa00350 Tyrosine metabolism - Homo sapiens (human) (4)



hsa:1312 COMT; catechol-O-methyltransferase (EC:2.1.1.6); K00545 catechol O-methyltransferase [EC:2.1.1.6]
hsa:1644 DDC, AADC; dopa decarboxylase (aromatic L-amino acid decarboxylase) (EC:4.1.1.28); K01593 aromatic-L-amino-acid decarboxylase [EC:4.1.1.28]
hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]
hsa:7054 TH, DYT14, DYT5b, TYH; tyrosine hydroxylase (EC:1.14.16.2); K00501 tyrosine 3-monooxygenase [EC:1.14.16.2]

hsa04930 Type II diabetes mellitus - Homo sapiens (human) (4)



hsa:774 CACNA1B, BIII, CACNL1A5, CACNN, Cav2.2; calcium channel, voltage-dependent, N type, alpha 1B subunit; K04849 voltage-dependent calcium channel N type alpha-1B
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:3099 HK2, DKFZp686M1669, HKII, HXK2; hexokinase 2 (EC:2.7.1.1); K00844 hexokinase [EC:2.7.1.1]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05220 Chronic myeloid leukemia - Homo sapiens (human) (4)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:613 BCR, ALL, BCR1, CML, D22S11, D22S662, FLJ16453, PHL; breakpoint cluster region (EC:2.7.11.1); K08878 breakpoint cluster region protein [EC:2.7.11.1]
hsa:1029 CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); K06621 cyclin-dependent kinase inhibitor 2A
hsa:9846 GAB2, KIAA0571; GRB2-associated binding protein 2; K08091 growth factor receptor bound protein 2-associated protein 2

hsa04270 Vascular smooth muscle contraction - Homo sapiens (human) (4)



hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa04920 Adipocytokine signaling pathway - Homo sapiens (human) (4)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:10645 CAMKK2, CAMKK, CAMKKB, KIAA0787, MGC15254; calcium/calmodulin-dependent protein kinase kinase 2, beta (EC:2.7.11.17); K07359 calcium/calmodulin-dependent protein kinase kinase [EC:2.7.11.17]
hsa:6258 RXRG, NR2B3, RXRC; retinoid X receptor, gamma; K08526 retinoid X receptor gamma
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa05212 Pancreatic cancer - Homo sapiens (human) (4)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:675 BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCB, FANCD, FANCD1, GLM3, PNCA2; breast cancer 2, early onset; K08775 breast cancer 2 susceptibility protein
hsa:1029 CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); K06621 cyclin-dependent kinase inhibitor 2A
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]

hsa00670 One carbon pool by folate - Homo sapiens (human) (3)



hsa:4522 MTHFD1, MTHFC, MTHFD; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase (EC:1.5.1.5 6.3.4.3 3.5.4.9); K00288 methylenetetrahydrofolate dehydrogenase (NADP+) / methenyltetrahydrofolate cyclohydrolase / formyltetrahydrofolate synthetase [EC:1.5.1.5 3.5.4.9 6.3.4.3]
hsa:4524 MTHFR; methylenetetrahydrofolate reductase (NAD(P)H) (EC:1.5.1.20); K00297 methylenetetrahydrofolate reductase (NADPH) [EC:1.5.1.20]
hsa:4548 MTR, FLJ33168, FLJ43216, FLJ45386, MS, cblG; 5-methyltetrahydrofolate-homocysteine methyltransferase (EC:2.1.1.13); K00548 5-methyltetrahydrofolate--homocysteine methyltransferase [EC:2.1.1.13]

hsa05330 Allograft rejection - Homo sapiens (human) (3)



hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa00340 Histidine metabolism - Homo sapiens (human) (3)



hsa:217 ALDH2, ALDH-E2, ALDHI, ALDM, MGC1806; aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3); K00128 aldehyde dehydrogenase (NAD+) [EC:1.2.1.3]
hsa:1644 DDC, AADC; dopa decarboxylase (aromatic L-amino acid decarboxylase) (EC:4.1.1.28); K01593 aromatic-L-amino-acid decarboxylase [EC:4.1.1.28]
hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]

hsa05130 Pathogenic Escherichia coli infection - Homo sapiens (human) (3)



hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:4691 NCL, C23, FLJ45706, FLJ59041; nucleolin; K11294 nucleolin
hsa:51807 TUBA8, TUBAL2; tubulin, alpha 8; K07374 tubulin alpha

hsa04964 Proximal tubule bicarbonate reclamation - Homo sapiens (human) (3)



hsa:476 ATP1A1, MGC3285, MGC51750; ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:477 ATP1A2, FHM2, MGC59864, MHP2; ATPase, Na+/K+ transporting, alpha 2 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]
hsa:478 ATP1A3, DYT12, MGC13276, RDP; ATPase, Na+/K+ transporting, alpha 3 polypeptide (EC:3.6.3.9); K01539 sodium/potassium-transporting ATPase subunit alpha [EC:3.6.3.9]

hsa04740 Olfactory transduction - Homo sapiens (human) (3)



hsa:157 ADRBK2, BARK2, GRK3; adrenergic, beta, receptor kinase 2 (EC:2.7.11.15); K00910 beta-adrenergic-receptor kinase [EC:2.7.11.15]
hsa:817 CAMK2D, CAMKD, DKFZp686G23119, DKFZp686I2288, MGC44911; calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:119694 OR51F2, OR11-23; olfactory receptor, family 51, subfamily F, member 2; K04257 olfactory receptor

hsa00534 Glycosaminoglycan biosynthesis - heparan sulfate - Homo sapiens (human) (3)



hsa:2134 EXTL1, EXTL, MGC70794; exostoses (multiple)-like 1 (EC:2.4.1.224); K02368 alpha-1,4-N-acetylglucosaminyltransferase EXTL1 [EC:2.4.1.224]
hsa:9394 HS6ST1, DKFZp547H098, FLJ25392, HS6ST, MGC116899, MGC116901; heparan sulfate 6-O-sulfotransferase 1 (EC:2.8.2.-); K02514 heparan sulfate 6-O-sulfotransferase HS6ST1 [EC:2.8.2.-]
hsa:266722 HS6ST3, DKFZp761K2315; heparan sulfate 6-O-sulfotransferase 3 (EC:2.8.2.-); K08103 heparan sulfate 6-O-sulfotransferase HS6ST3 [EC:2.8.2.-]

hsa04350 TGF-beta signaling pathway - Homo sapiens (human) (3)



hsa:654 BMP6, VGR, VGR1; bone morphogenetic protein 6; K04663 bone morphogenetic protein 5/6/7/8
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04512 ECM-receptor interaction - Homo sapiens (human) (3)



hsa:3909 LAMA3, BM600, E170, LAMNA, LOCS, lama3a; laminin, alpha 3; K06240 laminin, alpha 3/5
hsa:5649 RELN, PRO1598, RL; reelin; K06249 reelin [EC:3.4.21.-]
hsa:6383 SDC2, HSPG, HSPG1, SYND2; syndecan 2; K06257 syndecan

hsa05219 Bladder cancer - Homo sapiens (human) (3)



hsa:1029 CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); K06621 cyclin-dependent kinase inhibitor 2A
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:4318 MMP9, CLG4B, GELB, MANDP2, MMP-9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35); K01403 matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]

hsa04910 Insulin signaling pathway - Homo sapiens (human) (3)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3099 HK2, DKFZp686M1669, HKII, HXK2; hexokinase 2 (EC:2.7.1.1); K00844 hexokinase [EC:2.7.1.1]

hsa04115 p53 signaling pathway - Homo sapiens (human) (3)



hsa:1029 CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); K06621 cyclin-dependent kinase inhibitor 2A
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:9540 TP53I3, PIG3; tumor protein p53 inducible protein 3; K10133 tumor protein p53-inducible protein 3 [EC:1.-.-.-]

hsa04614 Renin-angiotensin system 

- Homo sapiens (human) (2)

hsa:1636 ACE, ACE1, CD143, DCP, DCP1, MGC26566, MVCD3; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1); K01283 peptidyl-dipeptidase A [EC:3.4.15.1]
hsa:183 AGT, ANHU, FLJ92595, FLJ97926, SERPINA8; angiotensinogen (serpin peptidase inhibitor, clade A, member 8); K09821 angiotensinogen

hsa04150 mTOR signaling pathway - Homo sapiens (human) (2)



hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1

hsa00010 Glycolysis / Gluconeogenesis - Homo sapiens (human) (2)

hsa:217 ALDH2, ALDH-E2, ALDHI, ALDM, MGC1806; aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3); K00128 aldehyde dehydrogenase (NAD+) [EC:1.2.1.3]
hsa:3099 HK2, DKFZp686M1669, HKII, HXK2; hexokinase 2 (EC:2.7.1.1); K00844 hexokinase [EC:2.7.1.1]

hsa00360 Phenylalanine metabolism - Homo sapiens (human) (2)

hsa:1644 DDC, AADC; dopa decarboxylase (aromatic L-amino acid decarboxylase) (EC:4.1.1.28); K01593 aromatic-L-amino-acid decarboxylase [EC:4.1.1.28]
hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]

hsa04140 Regulation of autophagy - Homo sapiens (human) (2)

hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:5289 PIK3C3, MGC61518, VPS34, hVps34; phosphoinositide-3-kinase, class 3 (EC:2.7.1.137); K00914 phosphatidylinositol 3-kinase [EC:2.7.1.137]

hsa03030 DNA replication - Homo sapiens (human) (2)

hsa:5427 POLE2, DPE2; polymerase (DNA directed), epsilon 2 (p59 subunit) (EC:2.7.7.7); K02325 DNA polymerase epsilon subunit 2 [EC:2.7.7.7]
hsa:5983 RFC3, MGC5276, RFC38; replication factor C (activator 1) 3, 38kDa; K10756 replication factor C subunit 3/5

hsa04610 Complement and coagulation cascades - Homo sapiens (human) (2)

hsa:624 BDKRB2, B2R, BK-2, BK2, BKR2, BRB2, DKFZp686O088; bradykinin receptor B2; K03916 bradykinin receptor B2
hsa:1361 CPB2, CPU, PCPB, TAFI; carboxypeptidase B2 (plasma) (EC:3.4.17.20); K01300 carboxypeptidase B2 [EC:3.4.17.20]

hsa04142 Lysosome - Homo sapiens (human) (2)

hsa:9114 ATP6V0D1, ATP6D, ATP6DV, FLJ43534, P39, VATX, VMA6, VPATPD; ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 (EC:3.6.3.14); K02146 V-type H+-transporting ATPase subunit AC39 [EC:3.6.3.14]
hsa:27074 LAMP3, CD208, DC_LAMP, DC-LAMP, DCLAMP, LAMP, LAMP-3, TSC403; lysosomal-associated membrane protein 3; K06562 lysosomal-associated membrane protein 3

hsa05320 Autoimmune thyroid disease - Homo sapiens (human) (2)

hsa:1493 CTLA4, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, ICOS, IDDM12; cytotoxic T-lymphocyte-associated protein 4; K06538 cytotoxic T-lymphocyte-associated protein 4
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10

hsa04623 Cytosolic DNA-sensing pathway - Homo sapiens (human) (2)

hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6

hsa00260 Glycine, serine and threonine metabolism - Homo sapiens (human) (2)

hsa:1610 DAO, DAAO, DAMOX, MGC35381, OXDA; D-amino-acid oxidase (EC:1.4.3.3); K00273 D-amino-acid oxidase [EC:1.4.3.3]
hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]

hsa00564 Glycerophospholipid metabolism - Homo sapiens (human) (2)

hsa:160851 DGKH, DGKeta, DKFZp761I1510; diacylglycerol kinase, eta (EC:2.7.1.107); K00901 diacylglycerol kinase [EC:2.7.1.107]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa05216 Thyroid cancer - Homo sapiens (human) (2)

hsa:6258 RXRG, NR2B3, RXRC; retinoid X receptor, gamma; K08526 retinoid X receptor gamma
hsa:83439 TCF7L1, TCF-3, TCF3; transcription factor 7-like 1 (T-cell specific, HMG-box); K04490 transcription factor 7-like 1

hsa00512 Mucin type O-Glycan biosynthesis - Homo sapiens (human) (2)

hsa:374378 GALNTL4, GALNT15, GALNT18, GalNAc-T15, MGC71806; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 4 (EC:2.4.1.41); K00710 polypeptide N-acetylgalactosaminyltransferase [EC:2.4.1.41]
hsa:6482 ST3GAL1, DKFZp666E036, DKFZp779K2051, FLJ36548, Gal-NAc6S, MGC9183, SIAT4A, SIATFL, ST3GalA, ST3GalA.1, ST3GalIA, ST3GalIA,1, ST3O; ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (EC:2.4.99.4); K00780 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4A) [EC:2.4.99.4]

hsa03060 Protein export - Homo sapiens (human) (2)

hsa:3309 HSPA5, BIP, FLJ26106, GRP78, MIF2; heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa); K09490 heat shock 70kDa protein 5
hsa:6729 SRP54; signal recognition particle 54kDa; K03106 signal recognition particle subunit SRP54

hsa00790 Folate biosynthesis - Homo sapiens (human) (2)

hsa:2643 GCH1, DYT14, DYT5, DYT5a, GCH, GTP-CH-1, GTPCH1, HPABH4B; GTP cyclohydrolase 1 (EC:3.5.4.16); K01495 GTP cyclohydrolase I [EC:3.5.4.16]
hsa:6697 SPR, SDR38C1; sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase) (EC:1.1.1.153); K00072 sepiapterin reductase [EC:1.1.1.153]

hsa03420 Nucleotide excision repair - Homo sapiens (human) (2)

hsa:5427 POLE2, DPE2; polymerase (DNA directed), epsilon 2 (p59 subunit) (EC:2.7.7.7); K02325 DNA polymerase epsilon subunit 2 [EC:2.7.7.7]
hsa:5983 RFC3, MGC5276, RFC38; replication factor C (activator 1) 3, 38kDa; K10756 replication factor C subunit 3/5

hsa04672 Intestinal immune network for IgA production - Homo sapiens (human) (2)

hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6

hsa00480 Glutathione metabolism - Homo sapiens (human) (2)

hsa:2539 G6PD, G6PD1; glucose-6-phosphate dehydrogenase (EC:1.1.1.49); K00036 glucose-6-phosphate 1-dehydrogenase [EC:1.1.1.49]
hsa:2878 GPX3, GPx-P, GSHPx-3, GSHPx-P; glutathione peroxidase 3 (plasma) (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]

hsa05310 Asthma - Homo sapiens (human) (2)

hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa04146 Peroxisome - Homo sapiens (human) (2)

hsa:1610 DAO, DAAO, DAMOX, MGC35381, OXDA; D-amino-acid oxidase (EC:1.4.3.3); K00273 D-amino-acid oxidase [EC:1.4.3.3]
hsa:6648 SOD2, IPOB, MNSOD, MVCD6; superoxide dismutase 2, mitochondrial (EC:1.15.1.1); K04564 superoxide dismutase, Fe-Mn family [EC:1.15.1.1]

hsa03040 Spliceosome - Homo sapiens (human) (2)

hsa:11325 DDX42, FLJ43179, RHELP, RNAHP, SF3b125; DEAD (Asp-Glu-Ala-Asp) box polypeptide 42 (EC:3.6.4.13); K12835 ATP-dependent RNA helicase DDX42 [EC:3.6.4.13]
hsa:9984 THOC1, HPR1, P84, P84N5; THO complex 1; K12878 THO complex subunit 1

hsa05416 Viral myocarditis - Homo sapiens (human) (2)

hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:6444 SGCD, 35DAG, CMD1L, DAGD, MGC22567, SG-delta, SGCDP, SGD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein); K12563 delta-sarcoglycan

hsa00603 Glycosphingolipid biosynthesis - globo series - Homo sapiens (human) (2)

hsa:10317 B3GALT5, B3GalT-V, B3GalTx, B3T5, GLCT5, beta3Gal-T5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5; K03877 beta-1,3-galactosyltransferase 5 [EC:2.4.1.-]
hsa:6482 ST3GAL1, DKFZp666E036, DKFZp779K2051, FLJ36548, Gal-NAc6S, MGC9183, SIAT4A, SIATFL, ST3GalA, ST3GalA.1, ST3GalIA, ST3GalIA,1, ST3O; ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (EC:2.4.99.4); K00780 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4A) [EC:2.4.99.4]

hsa03050 Proteasome - Homo sapiens (human) (2)

hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:9491 PSMF1, PI31; proteasome (prosome, macropain) inhibitor subunit 1 (PI31); K06700 proteasome inhibitor subunit 1 (PI31)

hsa00410 beta-Alanine metabolism - Homo sapiens (human) (2)

hsa:217 ALDH2, ALDH-E2, ALDHI, ALDM, MGC1806; aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3); K00128 aldehyde dehydrogenase (NAD+) [EC:1.2.1.3]
hsa:2571 GAD1, FLJ45882, GAD, SCP; glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15); K01580 glutamate decarboxylase [EC:4.1.1.15]

hsa00561 Glycerolipid metabolism - Homo sapiens (human) (2)

hsa:217 ALDH2, ALDH-E2, ALDHI, ALDM, MGC1806; aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3); K00128 aldehyde dehydrogenase (NAD+) [EC:1.2.1.3]
hsa:160851 DGKH, DGKeta, DKFZp761I1510; diacylglycerol kinase, eta (EC:2.7.1.107); K00901 diacylglycerol kinase [EC:2.7.1.107]

hsa00592 alpha-Linolenic acid metabolism - Homo sapiens (human) (1)

hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa00052 Galactose metabolism - Homo sapiens (human) (1)

hsa:3099 HK2, DKFZp686M1669, HKII, HXK2; hexokinase 2 (EC:2.7.1.1); K00844 hexokinase [EC:2.7.1.1]

hsa00240 Pyrimidine metabolism - Homo sapiens (human) (1)

hsa:5427 POLE2, DPE2; polymerase (DNA directed), epsilon 2 (p59 subunit) (EC:2.7.7.7); K02325 DNA polymerase epsilon subunit 2 [EC:2.7.7.7]

hsa03008 Ribosome biogenesis in eukaryotes - Homo sapiens (human) (1)

hsa:26354 GNL3, C77032, E2IG3, MGC800, NS; guanine nucleotide binding protein-like 3 (nucleolar); K14538 nuclear GTP-binding protein

hsa00430 Taurine and hypotaurine metabolism - Homo sapiens (human) (1)

hsa:2571 GAD1, FLJ45882, GAD, SCP; glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15); K01580 glutamate decarboxylase [EC:4.1.1.15]

hsa03018 RNA degradation - Homo sapiens (human) (1)

hsa:6499 SKIV2L, 170A, DDX13, HLP, SKI2, SKI2W, SKIV2; superkiller viralicidic activity 2-like (S. cerevisiae); K12599 antiviral helicase SKI2 [EC:3.6.4.-]

hsa00620 Pyruvate metabolism - Homo sapiens (human) (1)

hsa:217 ALDH2, ALDH-E2, ALDHI, ALDM, MGC1806; aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3); K00128 aldehyde dehydrogenase (NAD+) [EC:1.2.1.3]

hsa00280 Valine, leucine and isoleucine degradation - Homo sapiens (human) (1)

hsa:217 ALDH2, ALDH-E2, ALDHI, ALDM, MGC1806; aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3); K00128 aldehyde dehydrogenase (NAD+) [EC:1.2.1.3]

hsa00650 Butanoate metabolism - Homo sapiens (human) (1)

hsa:2571 GAD1, FLJ45882, GAD, SCP; glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15); K01580 glutamate decarboxylase [EC:4.1.1.15]

hsa00520 Amino sugar and nucleotide sugar metabolism - Homo sapiens (human) (1)

hsa:3099 HK2, DKFZp686M1669, HKII, HXK2; hexokinase 2 (EC:2.7.1.1); K00844 hexokinase [EC:2.7.1.1]

hsa00472 D-Arginine and D-ornithine metabolism - Homo sapiens (human) (1)

hsa:1610 DAO, DAAO, DAMOX, MGC35381, OXDA; D-amino-acid oxidase (EC:1.4.3.3); K00273 D-amino-acid oxidase [EC:1.4.3.3]

hsa00030 Pentose phosphate pathway - Homo sapiens (human) (1)

hsa:2539 G6PD, G6PD1; glucose-6-phosphate dehydrogenase (EC:1.1.1.49); K00036 glucose-6-phosphate 1-dehydrogenase [EC:1.1.1.49]

hsa00640 Propanoate metabolism - Homo sapiens (human) (1)

hsa:217 ALDH2, ALDH-E2, ALDHI, ALDM, MGC1806; aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3); K00128 aldehyde dehydrogenase (NAD+) [EC:1.2.1.3]

hsa00604 Glycosphingolipid biosynthesis - ganglio series - Homo sapiens (human) (1)

hsa:6482 ST3GAL1, DKFZp666E036, DKFZp779K2051, FLJ36548, Gal-NAc6S, MGC9183, SIAT4A, SIATFL, ST3GalA, ST3GalA.1, ST3GalIA, ST3GalIA,1, ST3O; ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (EC:2.4.99.4); K00780 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4A) [EC:2.4.99.4]

hsa00600 Sphingolipid metabolism - Homo sapiens (human) (1)

hsa:55304 SPTLC3, C20orf38, FLJ11112, FLJ90790, LCB2B, LCB3, SPT3, SPTLC2L, dJ718P11, dJ718P11.1; serine palmitoyltransferase, long chain base subunit 3 (EC:2.3.1.50); K00654 serine palmitoyltransferase [EC:2.3.1.50]

hsa00510 N-Glycan biosynthesis - Homo sapiens (human) (1)

hsa:79796 ALG9, CDG1L, DIBD1, DKFZp586M2420, FLJ21845, LOH11CR1J; asparagine-linked glycosylation 9, alpha-1,2-mannosyltransferase homolog (S. cerevisiae); K03846 alpha-1,2-mannosyltransferase [EC:2.4.1.-]

hsa05211 Renal cell carcinoma - Homo sapiens (human) (1)

hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]

hsa03013 RNA transport - Homo sapiens (human) (1)

hsa:9984 THOC1, HPR1, P84, P84N5; THO complex 1; K12878 THO complex subunit 1

hsa05131 Shigellosis - Homo sapiens (human) (1)

hsa:375189 PFN4; profilin family, member 4; K05759 profilin

hsa00270 Cysteine and methionine metabolism - Homo sapiens (human) (1)

hsa:4548 MTR, FLJ33168, FLJ43216, FLJ45386, MS, cblG; 5-methyltetrahydrofolate-homocysteine methyltransferase (EC:2.1.1.13); K00548 5-methyltetrahydrofolate--homocysteine methyltransferase [EC:2.1.1.13]

hsa00250 Alanine, aspartate and glutamate metabolism - Homo sapiens (human) (1)

hsa:2571 GAD1, FLJ45882, GAD, SCP; glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15); K01580 glutamate decarboxylase [EC:4.1.1.15]

hsa03430 Mismatch repair - Homo sapiens (human) (1)

hsa:5983 RFC3, MGC5276, RFC38; replication factor C (activator 1) 3, 38kDa; K10756 replication factor C subunit 3/5

hsa00040 Pentose and glucuronate interconversions - Homo sapiens (human) (1)

hsa:217 ALDH2, ALDH-E2, ALDHI, ALDM, MGC1806; aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3); K00128 aldehyde dehydrogenase (NAD+) [EC:1.2.1.3]

hsa04966 Collecting duct acid secretion - Homo sapiens (human) (1)

hsa:9114 ATP6V0D1, ATP6D, ATP6DV, FLJ43534, P39, VATX, VMA6, VPATPD; ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 (EC:3.6.3.14); K02146 V-type H+-transporting ATPase subunit AC39 [EC:3.6.3.14]

hsa00071 Fatty acid metabolism - Homo sapiens (human) (1)

hsa:217 ALDH2, ALDH-E2, ALDHI, ALDM, MGC1806; aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3); K00128 aldehyde dehydrogenase (NAD+) [EC:1.2.1.3]

hsa04130 SNARE interactions in vesicular transport - Homo sapiens (human) (1)

hsa:6616 SNAP25, FLJ23079, RIC-4, RIC4, SEC9, SNAP, SNAP-25, bA416N4.2, dJ1068F16.2; synaptosomal-associated protein, 25kDa; K08508 synaptosomal-associated protein, 23kDa

hsa00500 Starch and sucrose metabolism - Homo sapiens (human) (1)

hsa:3099 HK2, DKFZp686M1669, HKII, HXK2; hexokinase 2 (EC:2.7.1.1); K00844 hexokinase [EC:2.7.1.1]

hsa04975 Fat digestion and absorption - Homo sapiens (human) (1)

hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa05100 Bacterial invasion of epithelial cells - Homo sapiens (human) (1)

hsa:1496 CTNNA2, CAP-R, CAPR, CT114, CTNR, DKFZp686H02198; catenin (cadherin-associated protein), alpha 2; K05691 catenin (cadherin-associated protein), alpha

hsa00591 Linoleic acid metabolism - Homo sapiens (human) (1)

hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa00982 Drug metabolism - cytochrome P450 - Homo sapiens (human) (1)

hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]

hsa00524 Butirosin and neomycin biosynthesis - Homo sapiens (human) (1)

hsa:3099 HK2, DKFZp686M1669, HKII, HXK2; hexokinase 2 (EC:2.7.1.1); K00844 hexokinase [EC:2.7.1.1]

hsa00051 Fructose and mannose metabolism - Homo sapiens (human) (1)

hsa:3099 HK2, DKFZp686M1669, HKII, HXK2; hexokinase 2 (EC:2.7.1.1); K00844 hexokinase [EC:2.7.1.1]

hsa03015 mRNA surveillance pathway - Homo sapiens (human) (1)

hsa:5522 PPP2R2C, B55-GAMMA, IMYPNO, IMYPNO1, MGC33570, PR52, PR55G; protein phosphatase 2, regulatory subunit B, gamma (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B

hsa00601 Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human) (1)

hsa:10317 B3GALT5, B3GalT-V, B3GalTx, B3T5, GLCT5, beta3Gal-T5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5; K03877 beta-1,3-galactosyltransferase 5 [EC:2.4.1.-]

hsa03410 Base excision repair - Homo sapiens (human) (1)

hsa:5427 POLE2, DPE2; polymerase (DNA directed), epsilon 2 (p59 subunit) (EC:2.7.7.7); K02325 DNA polymerase epsilon subunit 2 [EC:2.7.7.7]

hsa04622 RIG-I-like receptor signaling pathway - Homo sapiens (human) (1)

hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2

hsa00310 Lysine degradation - Homo sapiens (human) (1)

hsa:217 ALDH2, ALDH-E2, ALDHI, ALDM, MGC1806; aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3); K00128 aldehyde dehydrogenase (NAD+) [EC:1.2.1.3]

hsa00533 Glycosaminoglycan biosynthesis - keratan sulfate - Homo sapiens (human) (1)

hsa:6482 ST3GAL1, DKFZp666E036, DKFZp779K2051, FLJ36548, Gal-NAc6S, MGC9183, SIAT4A, SIATFL, ST3GalA, ST3GalA.1, ST3GalIA, ST3GalIA,1, ST3O; ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (EC:2.4.99.4); K00780 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4A) [EC:2.4.99.4]

hsa00565 Ether lipid metabolism - Homo sapiens (human) (1)

hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa00140 Steroid hormone biosynthesis - Homo sapiens (human) (1)

hsa:1312 COMT; catechol-O-methyltransferase (EC:2.1.1.6); K00545 catechol O-methyltransferase [EC:2.1.1.6]

hsa00053 Ascorbate and aldarate metabolism - Homo sapiens (human) (1)

hsa:217 ALDH2, ALDH-E2, ALDHI, ALDM, MGC1806; aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3); K00128 aldehyde dehydrogenase (NAD+) [EC:1.2.1.3]

hsa05150 Staphylococcus aureus infection - Homo sapiens (human) (1)

hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10

hsa03440 Homologous recombination - Homo sapiens (human) (1)

hsa:675 BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCB, FANCD, FANCD1, GLM3, PNCA2; breast cancer 2, early onset; K08775 breast cancer 2 susceptibility protein

hsa04320 Dorso-ventral axis formation - Homo sapiens (human) (1)

hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]